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Interventional cardiac treatment has important effects on different aspects 
of the quality of life (QOL) of children with the congenital heart disease, so a 
hospital based cross sectional study was conducted at Sudan Heart Centre, 
during the period from March to September 2006. It included 72 children with 
congenital heart disease with a mean age of 7year (range: 6months-18years). 
These children received interventional cardiac treatment (66.7% of them had 
surgical procedures while26.4% had therapeutic catheterization and 6.9% had 
both surgical and catheter treatment), and their quality of life was studied in 
different aspects. The mean follow-up period was 1.08year.  
       It was found that (52.8%) of these children had interventional treatment 
at age > 5years. The majority of these children (97.3%) felt that their general 
health was good or very good after treatment. Eighty six percent of these 
patients had no further hospitalization, (68.1%) of them stopped medication, 
while (19.4%) decreased their use, and (9.7%) had more medications after 
treatment. Most of the patients showed much improvement in their symptoms 
(51.39%), nutritional intake (79.2%), social interaction and physical activity 
(91.7%).A considerable number of children suffered from parents over 
protection as (52.7%) were given the same or even more family attention. There 
was improvement of the children weight gain and height in (69.4%) after 
treatment.   A quality of life (QOL) score was formulated consisting of; (1) signs 
 iii
and symptoms (2) general well-being (3) frequency of hospitalization (4) growth 
state (5) social interaction (6) physical activity (7) dependency on family. It 
showed that (88.89%) of these children had good QOL after interventional 
treatment, while (11.11%) of them had poor QOL.   
           Although interventional cardiac treatment in Sudan had been recently 
introduced this study had shown that, most children benefited from this 
treatment and enjoyed a better QOL. With improving early diagnosis and 
treatment this percentage is expected to increase. 
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  ﺔﻣﻠﺨﺺ اﻻﻃﺮوﺣ
ﺍﻟﻌﻼﺝ ﺍﻟﺘﺩﺨﻠﻰ ﻟﻠﻘﻠﺏ ﻟﻪ ﺘﺎﺜﻴﺭﺍﺕ ﻫﺎﻤﻪ ﻋﻠﻰ ﺍﻻﻭﺠﻪ ﺍﻟﻤﺨﺘﻠﻔﻪ ﻟﻨﻭﻋﻴﻪ ﺍﻟﺤﻴﺎﻩ ﻟﺩﻯ ﺍﻻﻁﻔﺎل ﺫﻭﻯ ﺍﻋﺘﻼل ﺍﻟﻘﻠﺏ 
ﻩ ﺍﻟﺩﺭﺍﺴﻪ ﻟﻌﻴﻨﻪ ﻨﻤﻭﺯﺠﻴﻪ ﻓﻰ ﻤﺭﻜﺯ ﺍﻟﺴﻭﺩﺍﻥ ﻟﻠﻘﻠﺏ ﺨﻼل ﺍﻟﻔﺘﺭﻩ ﻤﻥ ﻤﺎﺭﺱ ﺫ ﻟﺫﺍ ﺍﺠﺭﻴﺕ ﻫ.ﺍﻟﺨﻠﻘﻰ ﺍﻟﻭﻻﺩﻯ
ﺴﻨﻭﺍﺕ 7ل ﻗﻠﺒﻰ ﺨﻠﻘﻰ ﻭﻻﺩﻯ ﻤﺘﻭﺴﻁ ﺍﻋﻤﺎﺭﻫﻡ  ﺘﻀﻤﻨﺕ ﺍﺜﻨﺎﻥ ﻭﺴﺒﻌﻭﻥ ﻁﻔل ﺫﻭﻯ ﺍﻋﺘﻼ.ﻡ6002ﺍﻟﻰ ﺴﺒﺘﻤﺒﺭ
,  ﺍﺠﺭﺍﺀ ﺠﺭﺍﺤﻰ  %  7.66ﺘﻠﻘﻰ ﻫﺅﻻﺀ ﺍﻻﻁﻔﺎل ﻋﻼﺝ ﺘﺩﺨﻠﻰ ﺒﺎﻟﻘﻠﺏ ﺒﻨﺴﺒﻪ (   ﺴﻨﻪ81-ﺍﺸﻬﺭ6ﺘﺘﺭﺍﻭﺡ ﺒﻴﻥ )
 ﻓﻰ ﻭﻤﻥ ﺜﻡ ﺘﻤﺕ ﺩﺭﺍﺴﻪ ﻨﻭﻋﻴﻪ ﺤﻴﺎﺘﻬﻡ,  ﻭﻗﺴﻁﺭﻩ ﻋﻼﺠﻴﻪﻲﺍﺠﺭﺍﺀ ﺠﺭﺍﺤ% 9.6ﻗﺴﻁﺭﻩ ﻋﻼﺠﻴﻪ ﻭ  % 4.62
  . ﺍﻭﺠﻬﻬﺎ ﺍﻟﻤﺨﺘﻠﻔﻪ
 ﺘﻠﻘﻰ ﺍﺠﺭﺍﺀ ﺘﺩﺨﻠﻰ ﻓﻰ ﻋﻤﺭ ﺍﻜﺒﺭ ﻤﻥ ﺨﻤﺴﻪ ﺴﻨﻭﺍﺕ %8.25 ﺍﻥ ﻭﺠﺩ.ﺴﻨﻪ80.1ﺘﺎﺒﻌﻪ  ﻜﺎﻥ ﻤﺘﻭﺴﻁ ﻓﺘﺭﻩ ﺍﻟﻤ
ﺜﻤﺎﻨﻴﻪ ﻭﺴﺘﻭﻥ .ﻤﻪ ﺠﻴﺩﻩ ﺍﻭ ﺠﻴﺩﻩ ﺠﺩﺍ ﺍﻟﻌﺎﺱ ﺒﺎﻥ ﺼﺤﺘﻪﺍﺤ %3.79ﺍﻟﻐﺎﻟﺒﻴﻪ ﺍﻟﻌﻅﻤﻪ ﻤﻥ ﻫﺅﻻﺀ ﺍﻻﻁﻔﺎل .
ﻤﻨﻬﻡ ﺍﻭﻗﻑ ﺍﻻﺩﻭﻴﻪ ﺒﻴﻨﻤﺎ % 1.86,ﻴﺩ  ﻤﻥ ﺍﻟﺩﺨﻭل ﻟﻠﻤﺴﺘﺸﻔﻰﺯﺒﺎﻟﻤﺎﺌﻪ ﻤﻥ ﻫﺅﻻﺀ ﺍﻟﻤﺭﻀﻰ ﻟﻴﺱ ﻟﺩﻴﻪ ﻤ
ﺍﻅﻬﺭ ﻤﻌﻅﻡ ﺍﻟﻤﺭﻀﻰ ﺘﺤﺴﻥ ﻓﻰ ﺍﻻﻋﺭﺍﺽ . ﺘﻌﺎﻁﻰ ﺍﻻﺩﻭﻴﻪ ﺒﻌﺩ ﺍﻟﻌﻼﺝ% 7.9,  ﺍﺴﺘﺨﺩﺍﻤﻬﺎ ﻤﻥﻠلﻗ% 4.91
ﺍﻟﺘﻔﺎﻋل ﺍﻻﺠﺘﻤﺎﻋﻰ ﻭﺍﻟﻨﺸﺎﻁ ﺍﻟﻔﻴﺯﻴﺎﺌﻰ , % 2.97ﺨﻭﺫ ﺍﻟﺘﻐﺫﺅﻯ ﺒﻨﺴﺒﻪ ﺄﺍﻟﻤ, %93.15ﻭ ﺍﻟﻌﻼﻤﺎﺕ ﺒﻨﺴﺒﻪ 
% 7.25 ﻤﻥ ﺍﻟﺤﻤﺎﻴﻪ ﺍﻟﺯﺍﺌﺩﻩ ﻟﻠﻭﺍﻟﺩﻴﻥ ﺤﻴﺙ ﺍﻥ  ﻴﻌﺎﻨﻰ ﺍﻻﻁﻔﺎل ﻋﺩﺩ ﻤﻘﺩﺭ ﻤﻥ%.7.19ﺍﻟﻁﺒﻴﻌﻰ ﺒﻨﺴﺒﻪ 
ﻜﺎﻥ ﻫﻨﺎﻟﻙ ﺘﺤﺴﻥ ﻓﻰ ﺍﻭﺯﺍﻥ ﻭﺍﻁﻭﺍل ﺍﻻﻁﻔﺎل ﺒﻨﺴﺒﻪ . ﻜﺜﺭﺃﺍﺴﺘﺤﻭﺫ ﻋﻠﻰ ﻨﻔﺱ ﺍﻻﻫﺘﻤﺎﻡ ﺍﻻﺴﺭﻯ ﺍﻟﺴﺎﺒﻕ ﻭ
( 2)ﺍﻻﻋﺭﺍﺽ ﻭﺍﻟﻌﻼﻤﺎﺕ ( 1) ﻨﻭﻋﻴﻪ ﺍﻟﺤﻴﺎﻩ ﺍﻟﺫﻯ ﺘﻜﻭﻥ ﻤﻥ؛ ﻟﻘﻴﺎﺱﺘﻡ ﺍﻨﺸﺄ ﺤﺭﺯ. ﺒﻌﺩ ﺍﻟﻌﻼﺝ% 4.96
ﺍﻟﻨﺸﺎﻁ ﺍﻟﻔﻴﺯﻴﺎﺌﻰ ﺍﻟﻁﺒﻴﻌﻰ (6)ﺍﻟﺘﻔﺎﻋل ﺍﻻﺠﺘﻤﺎﻋﻰ (5)ﺤﺎﻟﻪ ﺍﻟﻨﻤﻭ( 4)ﺘﺭﺩﺩ ﺩﺨﻭل ﺍﻟﻤﺴﺘﺸﻔﻰ ( 3)ﺍﻟﺘﻌﺎﻓﻰ ﺍﻟﻌﺎﻡ 
ﺒﻌﺩ  ﻤﻥ ﻫﺅﻻﺀ ﺍﻻﻁﻔﺎل ﻟﺩﻴﻪ ﻨﻭﻋﻴﻪ ﺤﻴﺎﻩ ﺠﻴﺩﻩ% 98.88 ﺯﺃﻥ ﻫﺫﺍ ﺍﻟﺤﺭﻅﻬﺭﻭﺃ.  ﺍﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻻﺴﺭﻯ(7)
, ﺩﺨل ﺤﺩﻴﺜﺎ ﺃﺒﺎﻟﺭﻏﻡ ﺍﻥ ﺍﻟﻌﻼﺝ ﺍﻟﺘﺩﺨﻠﻰ ﻟﻠﻘﻠﺏ ﻓﻰ ﺍﻟﺴﻭﺩﺍﻥ . ﻟﺩﺒﻪ ﻨﻭﻋﻴﻪ ﺤﻴﺎﻩ ﺴﻴﺌﻪ% 11.11ﺒﻴﻨﻤﺎ , ﺍﻟﻌﻼﺝ
ﻤﻊ .  ﺍﺴﺘﻔﺎﺩ ﻤﻥ ﻫﺫﺍ ﺍﻟﻌﻼﺝ ﻭﺍﺴﺘﻤﺘﻊ ﺒﻨﻭﻋﻴﻪ ﺤﻴﺎﻩ ﺍﻓﻀلﺍﻭﻀﺤﺕ  ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﻪ ﺍﻥ ﻤﻌﻅﻡ ﻫﺅﻻﺀ ﺍﻻﻁﻔﺎل
                                                                       .ﺘﺤﺴﻥ ﺍﻟﺘﺸﺨﻴﺹ ﺍﻟﻤﺒﻜﺭ ﻭﺍﻟﻌﻼﺝ ﻴﺘﻭﻗﻊ ﺍﺭﺘﻔﺎﻉ ﻫﺫﻩ ﺍﻟﻨﺴﺒﻪ
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 vi
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Chapter one 
1. INTRODUCTION AND LITERATURE REVIEW  
 
1.1. Definition:                                                           
Congenital heart disease (CHD )  are  defects that affect  the heart 
and it is major blood vessels before birth, as a result of failure of 
the heart or the blood vessels near it to develop normally. These 
defects are ranging in severity from simple to complex 
abnormalities (1).  
1.2   HISTORICAL BACKGROUND:               
Since the sixteenth century many abnormalities of the hearts 
and blood vessels had been disclosed by post-mortem 
examination. The last 50 years of the 20th century was witnessed of 
staggering advances in virtually all aspect of paediatric cardiac 
medicine and surgery. In 1930; Dr Helen Taussing, characterized 
the clinical and fluoroscopic finding of wide variety of CHD, and 
published the material in a two volumes textbook in 1960 (2). In 
1936 Dr Maude Abbott of Montreal had published an Atlas of 
congenital heart defects that helped in giving clinical diagnosis 
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and surgical correction of CHD.  In 1938 successful ligation of the 
ductus arteriosus was accomplished and was a signal achievement 
in the era of surgery for CHD. In 1945, Craffoord and Nylin 
successfully repaired the coarctation of the aorta. Legendary 
Blalock-Taussing anastomosis had atremendous impact on the 
emergency field of cardiac surgery (3, 4, 5,). In 1954; Andref, 
Cournand and others shared the Nobel pries in medicine and 
physiology" for their discoveries concerning heart catheterization 
pathological changes in circulatory system". John H.Gibbon`s 
heart/lung by pass machine which was developed in the early 
1950s, set the stage for intracardiac surgery; a mechanical pump-
oxygenator that permitted "accurate visualization of structure 
within the heart for a period sufficient to permit precise corrective 
measure. Each of these innovations addressed congenital cardiac 
malformation and heralded one of the most successful 
rehabilitation programs in medical history. The last half of the 20th 
century witnessed remarkable diagnostic and therapeutic 
development in this field; the introduction of the M-mode 
cardiography and the other technique modalities and was the 
introduction of the catheter based therapy (6, 7, 8) .   
 - 3 -
The late 1990s, has witnessed major change in cardiac 
surgical treatment in Sudan. That was the introduction of open- 
heart surgery in Ahmed Gassim hospital. In the year 2000a tertiary 
cardiac centre (which is Sudan heart centre (SHC)) was then 
established. Interventional paediatric cardiac treatment was 
introduced in SHC first in 2001as surgical intervention then, in 
2004 cardiac specialized paediatric cardiac catheterization was 
started (9). Many of our children with congenital heart disease were 
offered the chance, the thing that stimulates us to have a look at 
their quality of life after such treatment. 
 
1.3.  Epidemiology: 
1.3.1. General view: 
Congenital heart disease affects 5 to 8 infant per 1000 live 
births(10).  The incidence is higher among still born (2%), abortuses 
(10-20%) and premature infants (2%) excluding patent ductus 
arteriosus. There are no racial differerance in the incidence rate of 
congenital heart disease, although some differences in the type of 
the lesions do occur (11). 
 - 4 -
The out look of CHD depends on the nature and severity of 
the lesion, the presence of associated abnormalities, and the 
availability of surgical or catheter-based intervention.  
The mortality rate for untreated CHD is high, and prior to the 
introduction of modern surgery, a study of babies born live with 
heart disease reported that up to one third would die with in the 
first month of life and 60% before the end of the first year (12). 
Congenital heart disease- related mortality was decreased by 39% 
from 1979 -1997, and the age of death increased for most of the 
defects(13). Recent figures indicate that 85% of newborns with 
congenital heart disease are expected to survive to adult life (14).  
There is no evidence of major variations in incidence of CHD 
based on racial, geographical, and socio-economic factors in 
developing countries(15,16). The last two decades in Africa, showed 
a growing awareness towards CHD as an important cause of 
morbidity and mortality(17). In Tanzania the incidence was 
reported to be 7 per 1000 live birth, and it was found to be 1.7 per 
1000 live birth in Kenya(18,19).   
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1.3.2.  Situation in Sudan: 
Sudan is similar to other African countries in its situation 
about congenital heart disease.  The prevalence of CHD was found 
to be 2.3 per 1000 live birth, in a study conducted in 1996 by 
Ibtisam Ibrahim(20).The pattern of congenital heart disease among 
Sudanese children studied in 2004, and was found to be 
comparable to pattern reported in other parts of the world(21). A 
recent study however, reported that the frequency of Ebstein 
malformation of Tricuspid valve (TV) was four times that reported 
in west literature(22). Elhag found in a study conducted over a 
period   of two year (1991-1993) that almost all types of CHD was 
present in Sudanese children, and the most common being VSD(23). 
Ethnic, residence distribution of CHD children studied in 2005 and 
found that the majority were belong to Arab tribe and were from 
urban areas(24). 
 1.4.  Perinatal Cardiac Physiology: 
The understanding of the physiology of the unique nature 
of fetal and neonatal circulation, as well as the concept of the 
transitional circulation had a profound impact on the development 
of treatment modalities in paediatric cardiology. Rudolph and his 
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colleagues have fully characterized the fetal circulation 
demonstrating the flow pattern of the great veins, the fetal 
channels including; ductus venosus and ductus arteriosus, and the 
obligatory right-to- left shunt at the level of the foramen ovale (FO) 
occurring in the fetus. The inefficient separation of the uptake and 
delivery circulation of the fetus is replaced by two distinct 
circulations in series after birth.  This parallel circulation is 
achieved by the closure of the arterial duct and the ductus 
venosus, the separation from the umbilical circulation, and the 
cessation of the right-to-left flow through the foramen ovale. 
Coincident with these changes, are a substantial increase in 
pulmonary blood flow and an increased out put from each 
ventricle. Clearly, ventilation, oxygenation, and umbilical cord 
occlusion are the gross events responsible for the transition from 
the fetal circulation pattern to the circulation pattern of the 
newborn. These phenomenas are mediated by neurohormonal, 
mechanical, and environmental factors(25-27).  
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1.5. Cardiac Anatomy and the Nosology of Congenital 
Heart Disease: 
Dr Mauice Lev and his colleagues described and 
characterized the entire spectrum of congenital malformed hearts 
and produced a number of classifications of various cardiac 
anomalies. Lev, Anderson, and Becker also provided detailed 
information about the specialized conduction tissue in the normal 
and malformed heart. Richard Van Praagh and his colleagues, 
provided in the early 1960s the frame work for segmental analysis 
of (CHD) (28-30).  The three segments identified were; the atria, the 
ventricular loop, and the great arteries. There are two schools of 
cardiac nomenclature; one by Van Praagh and his colleagues 
emphasizing the infundibular anatomy of both normal and 
congenitaly malformed hearts. The other by Dr Robert Anderson 
and his colleagues using the segmental approach(31-33) .      
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1.6.  Classification of Congenital Heart Disease: 
Congenital cardiac defects can be divided into two major 
groups based on the presence or absence of cyanosis:  Acyanotic 
Lesions, Cyanotic Lesions. 
1.6.1.  Acyanotic lesions:  
This group is further subdivided into: 
1.6.1.1. Lesions resulting in increased volume load:  
The most common of these being, lesions causing left-to-right 
shunt including; Atrial septal defect (ASD), Ventricular septal 
defect (VSD), Atrio-ventricular septal defect (AVSD, AVcanal) and 
Patent ductus arteriosus (PDA). 
1.6.1.2. Lesions resulting in increased pressure load : 
The most common are obstruction to ventricular out flow like 
Pulmonary stenosis (PS), Aortic stenosis (AS), and Coarctation of 
the aorta  (COA). Less common lesions are obstruction to 
ventricular inflow like Tricuspid or Mitral atresia and Cor 
triatrium. 
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1.6.2.1. Cyanotic lesions: 
This group is further subdivided into: 
1.6.2.1.1.  Lesions with decreased pulmonary blood flow (PBF): 
These  lesions include both an obstruction to PBF, at tricuspid 
valve, right ventricle(RV) or pulmonary valve level, and aright- to-
left( R-L) shunt ,(via patent foramen ovale( FO),ASD or VSD). 
Common lesions in this group include: Tricuspid atresia(TA), 
Tetrology of fallot (TOF), and various forms of a single ventricle 
with PS.     
1.6.2.1.2. Lesion with increased pulmonary blood flow: 
In this group there is no obstruction to pulmonary blood 
flow and cyanosis is caused by total mixing of systemic venous 
and pulmonary blood within the heart or by an abnormal 
ventricular-arterial connection, like transposition of great arteries 
(TGA). The total mixing lesions includes those with common atria 
or ventricle, Total anomalous pulmonary venous return (TAPVR), 
and Truncus arteriosus. The nine lesions which together make up 
(90%) of all cases are VSD, ASD, AVSD, PS, PDA, AS, COA, TOF 
and TGA, the remaining (10%) are rarer complex anomalies (11,34).    
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1.7.    Pathophysiology of Congenital Heart Disease: 
The anatomic and physiological changes in the heart and 
circulation due to any specific congenital cardio circulatory lesion 
are not static but rather progressive from prenatal life to 
adulthood. Thus, malformation that are benign or escape detection 
in childhood may become clinically significant in the adult (35). 
1.7.1.   Pathophysiology of a cyanotic lesions:   
                      1.7.1.1.    Left-to- right(R-L) shunt lesions:    
Examples of this group: 
A.  Ventricular Septal Defect (Vsd): 
A VSD may be located in the perimembranous septum or in 
the muscular septum. PDA and COA are frequently associated 
defects. In sub arterial or supracristial VSD, the aortic valve may 
prolapse through the VSD, with resultant aortic regurgitation 
(AR). The defects vary in size, ranging from a small defect without 
hemodynamic significance to large defects with pulmonary 
hypertension and congestive heart failure. In VSDs with small to 
moderate L-R shunt, a volume overload is placed on the LA and 
LV. PBF is increased to a varying degree, and pulmonary 
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hypertension may result. With long–standing large VSD, 
pulmonary vascular obstructive disease (PVOD) develops, with 
severe pulmonary hypertension and cyanosis from a R-L shunt.       
B. Patent ductus arteriosus (PDA):       
                There is a persistent patency of normal fetal structure 
between the pulmonary artery (PA) and the descending aorta. The 
magnitude of the L-R shunt is determined by the diameter and 
length of the ductus and the level of pulmonary vascular resistant 
(PVR) with a long–standing large ductus, pulmonary hypertension 
and PVOD may develop with a R-L shunt and cyanosis(36,37).                 
1.7.1.2. Lesions resulting in increased pressure load:            
An example of this group: 
Pulmonary stenosis (PS): 
Pulmonary stenosis may valvular(90%), or subvalvular 
(infundibular or supra valvular).  Dysplasia of the pulmonary 
valve is frequently seen with Noonan’s syndrome. Isolated 
infundibular PS is uncommon, it is usually associated with a large 
VSDas in TOF. Post stenotic dilatation of the main pulmonary 
artery (MPA) usually develops in valvular PS. Depending on the 
severity of the PS, a varying of degree of right ventricular 
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hypertrophy (RVH) is present; Dilatation of RV on the chest x-ray 
(CXR) does not result unless congestive heart failure( CHF) 
supervenes, which is usually very late.  
1.7.2.   Pathophysiology of cyanotic congenital heart disease: 
Example of this group: 
a. Transposition of Great Arteries (TGA):                                          
TGA is the most common cyanotic CHD in newborn. The 
aorta arises anteriorly from RV, and the PA arises posteriorly from 
the LV. This result in complete separation of the two circuits, with 
hypoxemic blood circulating in the body and oxygenated blood 
circulating in the pulmonary circuit.   Defects that permit mixing 
of these circulations; such as ASD, VSD and PDA, are necessary for 
survival.  A  VSD is present in (40%) of these cases and PS 
(valvular or subvalvular) occur in (30%-35%) of patients had VSD. 
In neonates with poor mixing of the two circulations, progressive 
hypoxemia and acidosis develop, with resulting in early death if 
no intervention was offered. CHF develop in the first week of life 
in many patients. The RV is the systemic ventricle.                 
B.  Tetrology of Fallot (TOF): 
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The original description of TOF includes four abnormalities: 
a large VSD, right ventricular out flow tract (ROVT) obstruction, 
RVH, and overriding of the aorta. How ever, only two 
abnormalities are important: a VSD large enough to equalize 
pressure in both ventricles and an RVOT obstruction. The RVOT 
may be in the form of infandibular stenosis, pulmonary valve 
stenosis or a combination of the two. In the most sever form of the 
anomaly the pulmonary valve is atretic (10%). Right aortic arch is 
present in (25%) of cases. Because of the nonrestrictive VSD, 
systolic pressures in the RVand the LV are identical. Depending on 
the degree of the RVOT obstruction, either an L-R or R-L shunt is 
present. With mild to moderate RV outflow obstruction and 
balanced shunt across the VSD (acyanotic TOF) occurs, and with a 
more sever degree of obstruction, an R-L shunt occurs (cyanotic 
TOF) .The major heart murmur audible in cyanotic TOF originates 
from the RVOT obstruction, rather than the VSD(11).   
1.8.    Diagnosis of Congenital Heart Disease: 
Cardiac catheterization became a reality in 1940s, as it was 
first used to diagnose the right side of the heart, and in 1940-1950s, 
it became available for infants and children for left sided lesions. 
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Single fixed-plane angiographic equipment evolved to biplane 
equipment by 1970s. Bargeron and his colleagues by mid 1970s 
introduced the axial angiography(38,39).  M-mode echocardiography 
was introduced in the 1970s, and in the early 1980s it was 
developed to the cross-sectional type. The color Doppler 
technology added yet another dimension to these non invasive 
imaging modalities. The transesophageal approach to cross-
sectional echocardiology has now extended to be used in very 
small infants. Contrast echo-cardiac CT, MRI, Single photon 
emission CT perfusion imaging, stress echocardiography, Tissue 
Doppler characterization, 3D-echo, and intravascular U|S are new 
imaging modalities(40). With these new modalities, considerable 
information about cardiac structure, function, myocardial 
perfusion and tissue characterization can be obtained. Fetal 
echocardiography has provided a new frontier for diagnosis, 
counseling and treatment.  
1.9.   Interventional   Treatment  
                      (Catheter and Surgical Based) 
1.9.1. Interventional catheterization: 
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The primary role of interventional procedures in the 
management of some CHD is established and their clinical utility 
broadens every day. Improvements and new developments in 
specifically designed paediatric equipment have played a 
significant role. It has clear implication on cost, as most of non 
surgical techniques are cheaper than surgery, and hospitalization 
is much shorter(41).   In 1953 Rubio-Alvarez, described the 
technique by which pulmonary stenosis could be relived using a 
catheter technique(42).  Quarter of a century later , Semb et al, using 
an inflated balloon-tipped angiographic catheter that reduced the 
out flow gradient of the main pulmonary artery(43). However, the 
introduction of static balloon dilation by Kan and his colleagues 
fostered the application of these therapeutic modalities. Over the 
last two decades, the technique has become the "treatment" of 
choice for pulmonary valve stenosis at any age and with any valve 
morphology. The safety and efficacy of the technique has been 
confirmed by numerous studies by Mccrindle and Kan(44,45) . But 
catheter- based therapy for CHD was clearly focused by the 
approach of Rashkind and Miller, who in 1966 demonstrated the 
role of balloon atrial septestomy as maneuver to promote mixing 
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at the atrial level in patient with TGA(46). The application of this 
technique  has changed the out come of those patients. Postmann 
et al first advocated a percutaneous technique for permanent 
closure of the arterial duct, which could be a chivied via femoral 
artery in the late 1960s, but this technique, was not widely used(47). 
The1980s had witnessed a virtual explosion of catheter-based 
therapy. Balloon dilation was offered to patients with aortic 
stenosis, valvular and sub valvular and a wide range of acquired 
obstruction (Mustard and Senning baffles, etc) (48). The use of 
catheter-introduced devices to closed CHD has produced good 
results, where catheter closure of the arterial duct with any type of 
catheter–delivered devices or coils became a standard practice. 
Currently, several devices (Clamshell, Helex, Button) are 
undergoing clinical trials for closure of small to moderate sized 
ASD also an adouble-umbrella device (i-e,lock clamshell occluder) 
for a trial septal defect had been use(49). In the late 1980s and 
throughout the1990s, there was increased experience with catheter 
closure of the muscular ventricular septal defect (VSD).  In 1999 
Transcatheter closure of VSD with the use of Amplatzer occluder 
was introduced(50). Other application of this technique includes 
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dilation of pulmonary out flow tract as in (TOF) and also used in 
tricuspid atresia. The introduction of endovascular stents has 
afforded a considerable improvement. Today, there are relatively 
few areas of cardiovascular system that have not been explored by 
the interventional paediatric cardiologist.  
1.9.2.     Complications of interventional catheterization 
Over the last decade the paediatric interventional 
laboratory, while continuing to play a significant role in the 
anatomic and hemodynamic diagnosis, has evolved a therapeutic 
function (51, 52). All such procedures, both diagnostic and 
interventional are associated with some risk. To this end, a number 
of studies have addressed the risk of each of invasive procedure (53, 
54), but they were either retrospective or had reviewed relatively a 
small number of patients. To achieve understanding of the relative 
risk of all such procedures a prospective 7-year study was 
undertaken by Renato in Toronto, Canada to determine the 
incidence of adverse effects and predisposing factors associated 
with paediatric intervention and diagnostic cardiac catheterization. 
The study analyzed 4.952 cardiac catheterization performed at a 
medium age of 2.9 year, with55% being a male 45% being a female. 
 - 18 -
It was found that one or more complications occurred in 436 cases 
(8.8%), and were classified as major in 102 and minor in 458. 
Arrhythmic complications were the most common major 
complication occurred in 128 cases (2.6%) the most common 
arrhythmic event was atrioventricular block, 5patients needed 
pacing during the procedure. Death occurred in seven cases 
(0.14%) as a direct complication of the procedure and was more 
common in infants (n=5).Other complication found to be, cardiac 
arrest, arterial thrombosis, venous thrombosis, bleeding, cardiac 
perforation, cardiac tamponade, air embolus, and infections.  
Independent factors for complications included a young patient's 
age undergoing interventional procedure(54). 
1.9.3.   Cardiac Surgery:  
Surgical intervention was first offered for CHD in 1930s, 
and prior to that few children survived to adulthood(55). By1950, 
some form of surgical palliation for CHD were firmly entrenched. 
"Palliative" surgery offered relief of major circulatory disturbances, 
and includes: PA banding Blalock-Taussing shunt, Blalock-Hanlon 
operation, Waterston's shunt, Pott`s operation, Gore-Tex 
interposition shunt and Noorwood procedure.                                                               
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'Definitive" surgery attempts to restore the cardiac anatomy 
to normal, and includes: Rastelli repair, Rashkind procedure, 
Senning procedure, Fontan procedure, Glenn shunt, Jateene 
procedure and Mustard techqunic(56). Pulmonary artery banding 
has been introduced in 1950s(57,58), and the introduction of cardio 
pulmonary by-pass was in the mid 1950s(59). In 1970s was the 
intracardiac repair for most of CHD was carried out by deep 
hypothermic circulatory arrest(60). In the early days of open heart 
surgery, the old children undergone primary repair procedures, 
and young children usually palliated. Then after the introduction 
of open heart surgery, the infants were able to undergo definitive 
repairs. Primary repair for most conditions was introduced by 
Castaneda and his colleagues at the children hospital in Boston. 
The Period 1950-1959, had witnessed the palliation of babies with 
TGA, with either Blalock-Hanlon arterial septectomy or one of 
partial venous switch operation(61). Mustard in 1950s, attempted an 
arterial switch operation with relocation of one coronary artery, 
but none of his patient survived(62). The contribution by Sennjng in 
1959, was a complete venous switch had the potential for saving 
the severely cyanotic baby  with complete transposition, but most 
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surgeons were unable to reproduce it with an acceptable surgical 
mortality(63).  Then in 1963 William Thornton Mustard, performed 
his successful inflow switch operation, but it could not be 
performed in young infants. In the next 10-15 years, after the 
successful introduction of Mustard or Sennjng procedure, a 
"Pandora's box" of complication was catalogued. Dr Adib Jatene 
from, Brazil had accomplished the anatomic repair that failed by 
Mustard(64,65). By late 1970s an arterial switch operation had 
become the procedure of choice for most patient of TGA with VSD. 
In the early 1980s Castaneda and his colleagues introduced the 
concept of neonatal arterial switch, and this soon become the 
procedure of choice(66-69). Similar drama can be found in the 
surgical history of TOF, complex pulmonary atresia with VSD, the 
hypoplastic left heart syndrome (HLHS) and other complex 
anomalies(70). Fontan and Baudet carried out a successful total right 
heart by pass in patients with tricuspid atresia, and provided long 
term palliation for that malformed heart not amenable for 
biventricular repair(71-73).   
Lupoglazoft .J .M and his colleagues carried out a study and 
they found that VSD with L-to-R shunt mortality is 5% and that all 
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inter ventricular communication with major pulmonary 
hypertension should be operated during the first year of life. For 
atria L-to-R shunts, surgery should be done before the age 4 to 5 
years. They also found that results of TOF repair is excellent with 
survival of more than 30years in 86% of the simple form, and that 
total correction of TGA improve the  survival to more than 90%. 
They concluded that all operable cardiac malformation should be 
performed before the end of the second year of life, allowing for 
nearly normal life both at home and school(74). CHD related 
mortality was decreased by 39% since 1978-1997 and the age at 
death was increased for most defects(13).   However, with increased 
sophistication of surgical and medical management, mortality is 
becoming a less prominent issue and the focus most shifts towards 
morbidity, functional status, quality of life and resource demands 
in both the short and long term outcome(75). 
1.9.4.    Post interventional treatment course: 
The field of cardiac intensive care is rapidly evolving with 
nearly simultaneous advances in surgical techniques and 
adjunctive therapies, respiratory care technology and monitoring, 
pharmacological research and development, computer and 
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electronics(76). The post operative course depends on numerous 
factors, the severity of congenital heart defect, the age, the 
condition of the patient prior to surgery, the event in the operating 
room, and the quality of post operative care(11).   
1.10. Quality Of Life (QOl) After Interventional 
Treatment 
In the international symposium on "Quality of life after 
open heart surgery" presented the experience in more than 20.000 
patients; Issues like early identification, operation of pre morbid 
personalities, psychological counseling before and after the 
operation, explanation of the true risks were stressed. Other points 
like, educational  programs in redefinition of family roles, 
stressing the important of returning to normal activity in 
education, employment and society, finical support though health 
insurance to cover the high cost of open heart surgery, and 
formulation of socioeconomic policies which encourage returning 
to work yield improvement in all patient groups . For CHD, 
emphasis was lead to the need to educate parents about the 
disease, the importance of open discussion between parent, patient 
and the paediatric cardiologist, and the role of the parent self 
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groups. Lastly, general awareness of patient abilities will facilitate 
their social integration and improve quality of life(77). 
1.10.1. The effect of interventional treatment on the 
clinical presentation 
1.10.1.1.Symptom and Signs:     Children with 
congenital heart disease can either present with symptoms of: (a) 
congestive heart failure; breathlessness (particularly after exertion 
of feeding or crying), sweating, poor feeding, recurrent chest 
infection, failure to thrive and cyanosis (b)can be asymptomatic 
discovered during routine examination(34).  
Symptoms of specific type of congenital heart disease are as 
follow: 
a- Clinical feature of L-R shunt lesions: quick tiring, slow 
growth, susceptibility to pneumonia, rapid or difficult breathing .If 
the duct is small, there may be no symptom. 
b- Clinical feature of Obstructive defects: cyanosis, chest 
pain, tiring easily, dizziness or fainting, congestive heart failure, 
and high blood pressure.   
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c- Clinical feature of cyanotic defects: may present with 
cyanosis, sudden rapid breathing or unconsciousness and 
shortness of breath and fainting during exercise(78).   
 
1.10.1.2 Physical Examination:  
The presence of cyanosis, respiratory distress, and stunted growth, 
associated malformation and chromosomal syndromes which are 
suspected by the presence of dysmorphic features, all are 
indicative for the presence of CHD. The presence or absence of a 
heart murmur is unreliable as basis for the diagnosis of CHD(79). In 
older children, clubbing of digits, and squatting to rest  are 
indicative of right-to- left shunts, while fatigue with exercise, 
tachycardia, dyspnea, orthopnea and pedal edema are signs of 
heart failure. Femoral and brachial pulses should be palpated, as 
they may be absent in infants with some obstructive lesions of the 
left sided of the heart, sometimes femoral pulses maybe palpable, 
but one or both brachial pulses may not be palpable(80).  Suspicion 
of cyanosis should by confirmed by the nitrogen washout test 
(Hyperoxia test). The infant is placed in (100%) oxygen for ten 
minutes. If the right radial arterial PO2 is less than113mmhg after 
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this test, a diagnosis of CHD can be confidently made, assuming 
lung disease and pulmonary hypertension of the new born have 
been excluded(81).  Accurate assessment of height, weight and head 
circumference and plotting them on standard growth charts is 
essential as both chronic HF and chronic cyanosis usually result in  
failure to thrive. Growth failure is usually manifested by poor 
weight gain. In a study conducted in U.K in children and adult 
with CHD, it was found that (89.7%) were symptomatic and 
(26.8%) reported at least one symptom that was relatively 
disabling. Breathlessness and palpitation were the most common 
symptoms, others found to have dizziness, depression, and 
cyanosis(82).   Two other studies from Unit States (U.S) examining 
health-related quality of life (QOL), reported conflicting results 
regarding the symptom experience. One study found that children 
with CHD were more likely to experience symptom-related 
distress than control(83). The second study however, detected no 
significant difference between children with CHD and normal 
control in symptom experience(84). An a third one carried among a 
heterogeneous group of adult with CHD found that (9.8%) 
reported disability as indicated by New York heart association 
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criteria (NYHAC) class111 or 1V functional classification(14).  In 
Canada in a high risk group of adult with single ventricle or 
systemic right ventricle, more patients reported disability with 
(13.3%) in class 111 and (4.3%) in class1V(85) . In Australia a study 
carried out by Tefuarani and his colleagues in the period 
between1978-1994 to assess the outcome in 125 children who had 
cardiac surgery and 31 who were found to be unsuitable for 
surgery. Results showed survival rate of 99%, 79%respectively. On 
reviewing those survivors, they found that 93% of the surgical 
patients were asymptomatic and all fulfilled the (NYHAC) 
class1or11. Mild pulmonary hypertension or residual defects of no 
hemodynamic significance were present in44%.In contrast, all 
survivors from the 18 children originally classified having 
inoperable lesion were symptomatic, all in NYHAC class111, 1V (86) .  
                   1.10.1.3. Health maintenance and general well-being: 
Health is state of complete physical, mental, and social well 
being and not merely the absence of disease or infirmity(87). To 
maintain the health of a child with CHD, regular visits should be 
scheduled to multidisciplinary team. The frequency of visits 
should be individualized depending on the condition of the child. 
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In these visits several issues should be discussed with the parents. 
These include the nature of their child's CHD, treatment options, 
nutrition, vaccination, endocarditic prophylaxis and 
recommendation for physical activity(88). Meijboom.F , from 
Netherlands studied 176 infants and children undergone surgical 
closure for VSD at younger age in 1968-1980. Their results showed 
that, the main interval after operation was 14.5+2.6 years.  84% of 
the patients were assessed to have good or very good health and 
89% had been free of medical or surgical intervention since the 
operation. At examination all patient were in good health. 84% of 
the patients had normal exercise capacity. Echocardiography 
demonstrated a small residual VSD in seven patients (6%) with no 
signs of pulmonary hypertension. No patient had symptomatic 
arrhythmia, and it was concluded that personal health assessment 
is comparable to that of normal population(89).  In Finland a study 
conducted by Heta and his colleagues to assessed the psychosocial 
outcome of finish patient who had been operated on for CHD 
during childhood, with median time of follow-up of 25.6year 
(range9-45) in part of there results 2227 of the patients (77%) 
described their general health as good, 22% as moderately good 
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and 1%as poor. Poor health attributed to a condition unrelated to 
the cardiac defect or its treatment. 5 patients with PDA considered 
being in poor condition because of their cardiac defect, and 
surprising no patient with TGA reported poor health. The 
commonest lesions were found to be PDA, COA, ASD TOF, TGA, 
PS and AS(90).      
1.10.2. The effect of interventional treatment on cardiac 
morbidity: 
Agnoletti.G and his colleagues conducted a study, to 
identify the predictive factors of interventional paediatric 
catheterization. They analyzed 1022 interventional procedures, 
considering several patient related variables like, age, weight, 
gender, etc. They analyzed variables linked to the environment, 
specifically the date of the examination, whether the operator 
remained in training, any break down in the installation, and error 
made by the operator. They found that the incidence of 
complications was 4.1%. Of those patients, 4 were died, 7needed 
urgent surgery, 5needed elective surgery, 3were hospitalized in 
the ICU and 8were recatheterized. They concluded that variables 
related to either patient or the environment of catheterization are 
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associated with increased risk of procedural complication, so 
knowledge of risk factors can improve paediatric interventional 
treatment(91). Hortkotte D and his colleagues, studied 
246consecutive patients, mean age 11.9+6.7years with primary or 
secondary complete repair of TOF between 1961 and1972. They 
found that 46 of the patients were re-operated, and 21had late 
death. Complications were arrhythmia, HF, and infective 
endocarditis. The hazard of arrhythmia was inconstant and 
increased with time from the initial operation, and young age at 
surgery result in significantly better long-term prognosis (p=0.03) 
(94).  Dysrthmias are important source of morbidity and mortality 
in   patient    with    CHD    after  interventional treatment, and are 
especially common in individuals who have undergone arterial 
switch repair for TGA, TOF or Fontan palliation for single 
ventricle, as reported by Le Roy(94).                  
1.10.3. The effect of interventional treatment on the use of   
Cardiac Medication 
Therapeutic measures are aimed at control of heart failure 
symptoms and the maintenance of normal growth.   
These measures can be either;     
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• Supportive therapy: is important to increase tissue  
oxygen supply and correct metabolic abnormalities.   
• Medical therapy: These include correction of 
hypoglycemia, acidemia, and administration of antibiotic 
if infection is a contributing factor. 
-  Inotropic agents: like (dopamine, digoxin)  
- Diuretics: like frusmide.   
- Vasodilators: those are angiotensin converting enzyme 
ACE inhibitors like Captopril and Enalpril(94,95). 
Other measures include a well balance diet, prevention of 
anemia, prophylaxis against bacterial endocarditis, and the usual 
immunization programmed. All the previous measures still of 
consideration post interventional therapy mainly in case of 
procedures complications, with especial attention to immunization 
schedule where measles-mumps-rubella vaccine should not be 
given with in 10 days of surgical procedure. It is best to avoid all 
immunization the week before and 6 week after heart surgery(96).  
In one study conducted in the Czech Republic, it was found that 
26.8% of CHD children aged 8-13years, require medication(97).  
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              In a study that conducted by Meijboom and his colleagues 
in 1968-1980, it was found that 89% of the operated CHD children 
had been free from any medical or surgical intervention since the 
operation (89).In Belgium a study conducted by Moons and his 
colleagues in a group of adult CHD patients, and they found that 
27% of them still using cardiac medication post the procedure(98).    
1.10.4. The effect of interventional treatment on the physical 
activity: 
Most patients who have mild CHD require no treatment, so 
parents and children should be made aware that normal life is 
expected and no restriction of the child activities is necessary. Even 
those of moderate to severe heart disease need not to be markedly 
restricted in their physical activity, and they can modify it 
according to their capacity to participate. Massin and his 
colleagues studied the physical activity pattern of 52 unselected 
children aged 7-14 years, after neonatal switch operation for TGA, 
and35children with repaired atria or ventricular defect and aged 
matched to 127healthy controls. They found that both cardiac 
groups were significantly less active than the control group when 
considering moderate and vigorous activity. After operation; only 
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27% of children engaged in more than 30 minutes a day of 
moderate activity, and 19%of them in 20 minutes a day of vigorous 
activity. Concluded that children after arterial switch operation 
just like other cardiac children, do not meet the guide line for 
physical activity. They recommended regular activity to offset 
adult sedentary behavior and to prevent cardiac atherosclerotic 
disease(99). In a study done in the Czech Republic study, poor 
exercise tolerance was reported by 3.2% of school aged children 
with CHD, however 59.5% of them reported participation in 
recreational sports, and 6.7% in competitive sports(97).    
Guidelines regarding activity level and sport participation 
for CHD children have been developed which is shown below in 
(1.10.4.1) . 
1.10.4.1. Recommendation for physical activity in CHD 
children: 
The recommendation is categories into;     
Category-1: No restriction for physical activity for patients 
with; ASD, VSD, PDA (without pulmonary obstruction), mild PS 
and AS. 
 - 33 -
Restriction of activity is not recommended for those with 
COA who are surgically repaired with normal BP and for children 
with TOF who surgically repaired with RV pressure<50mmHg. 
Category-11: Those are allowed moderate exercise, regular 
physical education classes, tennis and basketball. This group 
includes TGA, TA surgically repaired. 
Category-111: Those allowed light exercise .This group 
includes; ASD, VSD and PDA (with mild to moderate pulmonary 
obstruction), moderate AS, COA with hypertension, TOF 
(surgically repaired with RV pressure >50mmHg or marked 
cardiomegaly), TA palliated or inoperable.  
Category-1V: Moderate limitation (no participation in 
physical education classes) is recommended for children with; 
severe AS and PS. ASD, VSD, and PDA (with moderate to sever 
pulmonary obstruction). 
Category-V: Extreme limitation. Home or wheel chair 
bound(100). 
1.10.5. The effect of interventional treatment on the   
education and social interaction of CHD children 
          1.10.5.1. Education 
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CHD is often associated with intellectual, developmental, 
and academic late effects related to the disease itself or its 
treatment. It appears that children with CHD, and particularly 
those with cyanotic CHD, are at risk of significant impairment in 
visual spatial skills, visual motor skills and over all developmental 
progress speed. Early neurocognitive interventions, especially 
with younger children, may prove beneficial for remediation of 
some of these deficiencies(101). Intellectual development is likely to 
be compromised in some children who had developed chronic 
illness early in life(102). Impaired (central nervous system, 
developmental, and cognitive) have been widely reported in 
children with CHD(103,104).   Feeding problems, resulting in failure 
to thrive are common in infants and young children with CHD, 
and can result in impaired development and intellect(105).   Surgical 
intervention for CHD can results in significant increases in IQ 
scores, particularly among older children(106), and more specifically 
in those children with cyanotic lesions(107).  However even after 
correction of cyanotic lesions, considerable neurodevelopment and 
cognitive deficiencies may remain(108,109).  There is some evidence 
that postponing the repair of cyanotic lesions is associated with 
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progressive impairment in cognitive function. In children with 
acyanotic lesion, no relation has been found between age at 
surgery and cognitive impairment(105,106).   In 1999 Wary and his 
colleagues compared intellectual and developmental impairment 
in children with CHD children awaiting surgery, children waiting 
for bone marrow transplantation, and a control. The Results 
showed preoperatively, the cardiac and transplant groups showed 
intellect and development deficits compared to control.   
Postoperatively, continuing developmental deficits were 
significant only in children with cyanotic lesions. They concluded 
that before corrective surgery, chronic illness itself appears to have 
a predominant influence on development. Postoperatively, 
cyanotic and a cyanotic lesions are associated with different short 
term outcomes, where the cyanotic group showed significant 
deterioration in locomotors and personal/social functioning, the a 
cyanotic showed improvement in the above subscale that not reach 
statistical significant(110).   In a recent U.S study, 94% of adults with 
complex CHD had finished their high school education, and 62% 
of them finished college(111).  In other countries, however, academic 
problems have been reported in children with CHD, including 
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delayed school attendance in 35.5% and poor academic 
performance in 6.9%as found by Samanek(97).  
10.5.2. Social interaction: In several studies, adolescents 
and young adults with CHD have consistently been reported to be 
feeling different from their peers(111). Despite this, even adult with 
complex CHD reported "normal childhoods" and normal teen 
years. Nonetheless, the same subject how were reported "normal", 
also described to have feeling of social isolation and limitation in 
peer's interactions. Some researchers described this as denial, 
while others describe it as normalizing, strategy to deal with 
situation(112). An old study compared problems of behavior in 
children with complex CHD and those with innocent murmurs. It 
was found that children with complex CHD were more 
withdrawn, experienced more social problems, and engaged in 
fewer activities(113).  Turkish researcher identified worsening and 
severity of hemodynamic status, older age group at surgical repair, 
and others as predictive factors of behavioral problem; like 
depression, anxiety…etc(114).   Mccrindle and his colleagues studied 
537 patients; their mean age was 11.9year assessing their health 
state after Fontan procedure. They reported morbidities include 
 - 37 -
deficits in vision in33%, speech in27% and hearing in 7%, as well 
as problem with attention in 46%, learning in  43%, behavior in 
23%, anxiety in 17% and depression in 8%(115) .  In a study 
conducted to examine the psychosocial outcome of Finish patients 
who had been operated on for CHD during childhood, Heta and 
others found that they were living in steady relationship as often 
as the general population(90).     
1.10.6 Psychosocial impact on the children and their 
families post intervention: 
Chronisity of the disease reported to produce both negative 
and positive effects on the patient's life(116).  In many studies, good 
coping has resulted in excellent QOL, even for severely physically 
disabled patient(117).   In a European study conducted to assess the 
long term behavioral problems, among CHD children had repair 
surgery, they found that high score of problem was among the age 
group 10-14year. They related it to many factors; like numbers of 
cardiac procedure, prematurity, older age at surgical 
repair...etc(118).    
Difficulties in leading independent life was the most 
common negative effect reported by Utens and his colleagues(119) 
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as long term results of CHD surgically corrected. Knowledge of 
parents of CHD children, about their child heart disease, 
treatment, prevention of complications, type of interventional 
procedure they needed and its risk, and the post interventional 
course, may likewise promote a better health related behavior in 
their children by reinforcement of the positive, normal attributes of 
their children that help these families seeing their children as an 
individual with many of the same needs as healthy children. 
Children with cardiac defects may have entirely wrong concepts of 
their disease (120). In Sudan 2005 a study conducted, to asses 
parental knowledge, attitudes and practice towards their children 
heart disease and its impact on their growth, the result showed 
that 64% of the parents had poor knowledge(24). Another study 
conducted by Beeri and his colleagues to assess parental 
knowledge and attitudes among outpatients at a hospital 
paediatric cardiology clinic. They found 68% of the families turn to 
non-medical personnel for medical advice(121).  Andresova and 
other, in Czecholovakia investigated training attitudes of 18 
mothers of children age 6-14 years, operated during preschool age 
for CHD. All mothers preferred democratic training with 
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stimulation of the children's activities. They refused authoritative 
and restricting attitudes. Mothers did not display excessively 
centered relation to the child, nor exaggerated protectiveness(122). 
An a study conducted in UK by Noll S, and his colleague to 
characterize the source of additional medical information acquired 
by the parents and to verify how  much information is correctly 
interpreted and remember correctly. The conclusion was that 
parents commonly obtain additional medical information, 
however this information does not necessarily improve parent's 
understanding of the child's operative risk and long-term 
problems. In addition parents` perception of having adequate 
medical information often is incorrect(123).  
Families must be included as a part of the health care team, 
to assure that they have accurate information for making decisions 
about their child treatment(124). Consultation with a mental health 
professional may enable the family to recognize and build on 
strength that will help them cope with this challenge that might 
interfere with their coping abilities(125).  Physician awareness of 
community resources such as parent support groups and respite 
care is helpful to parents. When this process occurs the family 
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focuses on the child rather than on the condition. Reinforcing 
family's successes helps them build the confidence and desire to 
address and mange future issues(126). 
1.10.6. The effect of interventional treatment on the 
growth State and development progress of CHD 
children: 
Children with CHD often grow and develop more slowly 
than other children, i-e their height and weights are in lower 
"percentiles", and their development milestones such as (rolling 
over, sitting…etc), may be slower than healthy children. Falling 
behind in the growth and development in such children has 
several reasons; the inadequate nutrition that does not meet the 
body energy requirement, allowing for proper growth, and 
causing them tiring quickly to be physically keeping up with their 
peer of the same age. The illness and frequent or prolonged 
hospitalization may prevent the child from receiving stimuli that 
help with the development, such as being played with, talked to or 
touched.   
1.10.6.1. The effect on the growth: Growth impairment of 
CHD children is directly proportional to the presence of cyanosis 
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and to the severity of the hemodynamic disturbance (127). 
Acyanotic lesions tend to jeopardize weight gain rather than 
height, whereas cyanotic lesions tend to affect both height and 
weight(128,129), Linde and his colleagues found amore pronounced 
retardation in both weight and height in children with cyanosis 
than those with acyanotic lesions(130). Boys are usually more 
malnourished than girls(127,129). Much of the research on 
malnutrition and growth failure in CHD children are rather old 
and may not reflect outcomes with current medical and surgical 
technology. In a U.S study performed in the last decade, 52% of 
young children with CHD had weight below the third percentile, 
37% had their height below the third percentile, and 12%-25% had 
their skin fold thickness lying below the third percentile (131). A 
similar study carried out in Turkey revealed growth failure in 
more than 50%of children with CHD, and it identified cyanosis, 
pulmonary hypertension, and congestive heart failure to be 
significant factors for growth failure and malnutrition(132). In 
another study, Foster and his colleagues noted that these problems 
persist into adulthood, and that adult with CHD continue to 
struggle with physical appearance issues related to small 
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stature(133).  Delay of surgical repair of CHD can lead to worsening 
of nutrition and growth status of patients.  Several reports have 
documented more encouraging results of early repair of critical 
CHD in symptomatic neonates and infants compared to those of 
palliative operations(134). The effects of the interventional treatment 
on both weight and height of CHD children have been studied. 
Sasaki and his colleagues In Japan assessed seven short pre 
pubertal children with CHD, who had complete surgical correction 
and treated with recombinant human growth hormone (GH). 
Their growth rate increased from a mean of 4.3cm/year before 
treatment to a mean of 7.8cm/year in the first year and to a mean 
of 6.3 /year in the second year of treatment. Their mean 
standardized height also improved. They came to conclusion that 
recombinant GH increases the growth rate in children with 
congenital heart disease and in those with prepubertal growth 
retardation(135). 
In a study conducted in 2005 in Sudan, Leila El Mahadi 
found that more than half of CHD patients (55%) had weight 
below the 3rd. On the other hand (40%) had moderate to severe 
malnutrition, and (24%) had mild malnutrition. Thirty one patients 
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(31%) were found to be failing to thrive. The study included both 
CHD children had interventional treatment and those did not had 
it(24).   
1.10.6.2 Developmental Progress: 
The developmental progress of infant requiring early open 
heart surgery is currently being defined. Overall, severe 
neurological squeal are uncommon; however, mild to moderate 
developmental disabilities are prevalent. Functional limitation, 
academic achievements and health-related quality of life are areas 
that deserve further attention(136).    The use of cardiopulmonary by 
pass and/or deep hypothermic circulatory arrest intraoperatively 
increases the risk of neurodevelopmental abnormality(137).  In a 
prospective study conducted in Canada by Limperopoulos and his 
colleagues, to determine the prevalence of persistent 
developmental impairments in children with CHD, 131 infants age 
less than 2 years, were assessed before surgery and again 12-18 
month later with stander developmental assessment and formal 
neurological examination. Results showed that the mean age at 
follow up testing was19.1+6.6 months, assessment indicated, that 
41% had abnormal neurological examination. Gross and/or fine 
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motor delays were documented in 42%, and 23%demonstrateds 
global developmental delay. They concluded that children with 
CHD commonly have ongoing neurological, motor, and 
developmental deficits which continue well after surgical 
correction(138).    
In 2001 Weinberg and his colleagues found that more than 
46% of children with surgical or catheter intervention scored 
abnormal ratings on developmental screening. Those children 
were significantly more likely to be rated as abnormal, than 
children with hemodynamicaly insignificant congenital heart 
disease. They also    reported gross motor, personal and social skill 
delays(139). 
Wray and his colleagues looked into intellectual 
impairment among children with CHD. They compared three 
groups aged below three and half years; a group with CHD 
awaiting surgery, another waiting for bone marrow transplant, 
and a healthy group for control. Results showed that although the 
mean of the three groups were within normal range, 
preoperatively the cardiac and transplant groups showed some 
deficits on the locomotor area, personal/social, and speech and 
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hearing scale. Postoperatively continuing developmental deficits 
were significant only in the children with the cyanotic lesions(110). 
In assessing the neurodevelopmental outcome and life style in 143 
school-aged and adolescent children with HLHS, William and his 
colleagues found that 47.8% had fine motor abnormalities, 39.1% 
had gross motor abnormalities and 17.4% met the criteria for 
cerebral palsy (CP). Hemiparesis was noted in all 4 subjects with 
CP. No patient was found to have spastic quadriplegia(140).                                        
1.10.7. The effect of interventional treatment on the 
hematological indices: 
Treatment of iron deficiency anemia is especially important 
in cyanotic patients who will show improved exercise tolerance 
and general well-being with adequate hemoglobin levels; on the 
other hand, these patients should also be carefully observed for 
excessive polycythemia. Cyanotic patients should avoid situations 
in which dehydration occur, which might lead to increased 
viscosity and increased risk of stroke.   High altitudes and sudden 
changes in the environment should be avoided. Phlebotomy with 
volume replacement should be carried out in symptomatic 
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patients with severe polycythemia (hematocrit > 65%)(11).   There 
are no studies available on this issue.  
JUSTIFICATION AND OBJECTIVES 
   Justification: 
1. Congenital heart disease is a common health problem 
with a great burden on children.  
  2. Interventional treatment for congenital heart disease 
(surgical or catheter-based) which has been introduced 
recently in Sudan has important effects on the quality of life of 
these children. 
  3.   No similar study was done in Sudanese children before. 
    OBJECTIVES: 
1. General objective: 
• To evaluate the quality of life after interventional 
treatment for CHD children.  
2. Specific objective: 
To evaluate the effect of interventional treatment on the 
following:               
• Clinical symptoms and signs.   
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• General well-being.   
• Cardiac morbidity (Hospitalization and cardiac 
complications). 
• The use of cardiac medications  
• Physical activity. 
• Education and Social interaction. 
• Family's caring and children dependency. 
• Growth state (weight & height) and 
developmental    progress.  
•  Hematological indices (Hemoglobin & Packed 
cell volume). 
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Chapter Two 
2.   Patients and Methods 
 
2.1.   Nature of the Study: 
This is a hospital based, cross sectional descriptive study. 
2.2.   Study Area:  
The study is conducted in Sudan Heart Centre (SHC); 
which is atertiary paediatric cardiac center. It is located in Erkwit-
Khartoum, and is established in2000. It is running three paediatric 
clinics per week by two paediatric cardiologist and one general 
paediatrion. In addition there is paediatric surgical clinic run by 
one cardiac surgeon and one junior staff. There are two operating 
theatres; one is for open heart surgery. The catheter laboratory, 
where different procedures are available includes: diagnostic and 
therapeutic cardiac procedure. The combined (ICU/CCU) has 10 
monitored beds and 45 beds with central oxygen, suction, 
compressed air and other necessary equipment. There where about 
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300 operations per year and more than 1000 cardiac catheterization 
per year; 150 of these is paediatric procedure. 
2.3. Study Duration: 
 From fist of March to the end of July 2006.  
2.4. Study population: 
The study population is composed of children from six 
months to eighteen years attending Sudan Heart Centre (SHC) 
with Congenital Heart Disease (CHD) for which they had 
interventional treatment 6 months or more prior the time of 
interview. 
2.5. Case Definition: 
Interventional treatment: Refer to cardiac catheterization or heart 
surgery for CHD.  
2.6. Inclusion Criteria:  
All Children age between six months and eighteen years 
attending Sudan Heart Centre (SHC) with CHD for which they 
had interventional treatment 6months or more prior the time of 
interview, were included. 
 
 - 50 -
2.7. Exclusion Criteria: 
1. Syndromic children. 
2. Children and parents who refused to participate in the 
study.  
2.8. Sample Size: 
According to the equation below:   
                             N = Z2 x PQ 
                                        D2 
 N =    Sample size   
  Z =   Statistical certainty 1.96(at 95% of confidence)              
  P =     Prevalence= 5% 
  Q =     Probability of failure =I.0 - P 
  D =     Desired margin of error = 0.05 = correction factor  
 The sample size was calculated to be72 children. 
2.9. Ethical Approval: 
• Approval of the study was taken from our local 
committee of paediatric and child health university of 
Khartoum. 
• Approval from the consultants taking care of the 
patients 
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• Verbal informed consent was obtained from the 
children or their parents after explaining the 
objectives of the study. 
2.10.    Study Technique and Tools: 
2.10.1 Research team: 
• The Author. 
• A Paediatric cardiologist  
• A Laboratory technician.  
 2.10.2. Research tools: 
       Pre-structured questionnaire, to be filled by the author after   
explaining the purpose to child caretaker, and after taken a verbal 
consent at the outpatient clinic. 
       2.10.2.1. The Questionnaire was containing the following 
data: 
- Personal data of the patient such as name, age, gender, 
tribe, and residence.  
- Symptoms and signs of congenital heart disease before 
interventional treatment compared to those after treatment.  
- Number of hospitalization to be compared before and after 
treatment. 
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-  From the medical records the following data was collected;  
past history of cardiac complications, diagnosis, type of 
procedure, date of procedure, and post treatment 
complications. 
- Developmental assessment using; Denver developmental 
assessment (Denver 11). It is a tool for screening of the 
apparently normal child between the ages 0-6 years. It 
allows the practitioner to identify those children who may 
have developmental delay. The test screens the child in four 
areas: personal- social, fine motor, gross motor, and 
language(141) .   
 - Education; assessed by the level of education and 
school attendance which was evaluated by the number of 
days of absences per week.  Academic performance was 
evaluated in four degree as excellent, good, fair or poor and 
was compared to that before treatment. 
 - Social interaction: was assessed by the child 
interaction with peer and surrounds, and was compared to 
that before treatment. 
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 - Physical activity: was assessed by being compared 
to that before treatment, either better, less or remain the 
same in his/her activity. This is by asking the parents, and 
by assessing the degree of dyspnea according to the New 
York Heart Association Classification (NYHAC);   
      Class 1:    No breathlessness. 
     Class 11:  Breathlessness on sever exertion.  
      Class 111: Breathlessness on mild exertion.  
      Class 1v:   Breathlessness at rest.                    
- Family caring for the child: assessed by asking if 
remained the same to before treatment, becoming less or 
giving more care.  
-  The child's dependency on the family: assessed by 
asking  if it remained the same, less or becoming more 
dependant after treatment.  
-  The nutritional history; was evaluated by comparing to 
that before treatment.  
-  Drug history:  assessed the numbers of medications 
before and after treatment.  
 - 54 -
 The socioeconomic status of the patients was classified to 
low, moderate, and high state according to the national Sudanese 
income. 
 
 2.10.2.2.   Physical examination: 
 Through physical examination was conducted 
including:                                  
 2.10.2.2.1. General examination: for pallor, plethora, 
cyanosis, and lower limb edema.   
 2.10.2.2.2. Anthropometric measurements (weight and 
height):  
Weight: Weights of children were measured with light clothing 
without shoes and the error of weighting the children with 
underwear was corrected by subtracting 0.1kg.   
Supine length: was done up to the age of 2-3 years on a flat 
surface, was measured by holding the child under the mandible 
with the vertex against the head board and another person 
stretching the extended legs, with the foot board against the soles 
of the infant's feet. 
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Standing height:   done for children who are older than two year.  
It was taken without shoes, with child standing with heels against 
backstop with straight legs. Gentle pressure applied to mastoids to 
the extend neck and keep external auditory meatus and lower rim 
of orbit in a horizontal line while the child is looking slightly 
downwards. The upper part of the height scale is applied to the 
vertex of the skull at right angles to the back rest using a measure 
box (Shorr Board Tm USA)  
Nutritional status are classified according to the 
following: 
Table: 
HAZ:  Is height for age. 
WAZ: Is weight for age. 
WHZ: Is weight for height.(142) 
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 2.10.2.2.3.  Cardiovascular examination: The  children  were  
examined while they were calm and in acomfertable position. The 
examination include measurement of the blood pressure using an 
apropriate paediatric cuff covering two third of the upper left arm 
and plotted against normal for age.  The pulse characteristic 
including rate, volume,and character  were  determined from the 
radial artery and from the brachial artery in infants. The femoral 
artery is examined for a radio-femoral delay . The pericordium 
was then examined to locate the apex beat, presence of left para 
sternal heave, thills,and  murmers. Oxygen saturation assesssed by 
using pulse oximetry. The  lung bases were auscultated for basal 
crepitations.   
 2.10.2.2.4.   Abdominal examination: 
 Examination of the abdomen including palpation for 
hepatomegaly , splenomegly and percussing for ascites. 
 2.10.2.2.5. Central nervous system examination: 
 This included examination of the cranial nerves , upper 
limbs and lower limbs for power, tone and reflexes.   
 All the physical finding were compared to the data 
recorded before interventional treatment in the medical records. 
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2.10.3.  Investigations: The following investigations were done 
post-operative and compared with preoperative results: 
1. Hemoglobin level and packed cell volume (PCV). 
2. Echocardiography. 
3.  Cardiac Catheterization Results (in selected patients) are 
recorded. All the investigations were done in the SHC.  
 Echocardiography and cardiac catheterization was 
performed by a paediatric cardiologist before and after the 
treatment.  
2.10.4.   Data entry and statistical methods: 
The questionnaire was coded, and a master sheet was 
constructed to arrange the raw data. The tables were then 
drowned and descriptive statistics measured. Data was analyzed 
using computer program the Statistical Package for Social Sciences 
System (SPSS). Data was expressed as percentage. Univariate 
analysis to assess for association between demographic and 
clinical variable with selected items of clinical presentation, 
general well-being, cardiac morbidity, education, social 
interaction, and physical activity, use of medication, growth and 
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developmental progress was performed with the Chi-square test. 
Level of significance was set at p value <0.05.  
E 
      EPI-Info 2000 Statistical Package Computer Program was 
used to determine the nutritional status of children (boys and 
girls), by using the below indictors(133).  
Indicators produced were: 
WHZ (weight for height or length Z- score) 
SD (Standard Deviation) 
Z-score or Standard Deviation (SD) Score = is the deviation 
of the value for an individual from the median value of the 
reference population, divided by the standard deviation of the 
reference population: 
Z        =     Score or SD score = 
              (Observed value) – (median reference value) 
               --------------------------------------------------------------- 
              Standard deviation of reference population 
 
IF       WHZ was > - 2SD, i.e. mild malnutrition.         
IF        WHZ was > - 3SD, i.e. moderate malnutrition. 
IF        WHZ was < - 3 SD, i.e. sever malnutrition (142) 
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Scoring system was also used to assess the quality of life in 
different aspects; like signs and symptoms, general well-being, 
frequency of hospitalization, growth, physical activities, social 
interaction, and dependency on families after interventional 
therapy. Using score of two for better outcome in the QOL and one 
for the same out come, and zero for poor outcome. The total of the 
outcome results were analyzed and a cut-off point of (70%) was 
used to divide the outcome to good or poor QOL. Score of more 
than (70%) were considered as good quality of life and score equal 
or below (70%) were consider as poor QOL.      
2.10.5.   Potential  difficulties: 
• Insufficient data on out patient medical records. 
 
 
 
 
 
 
 
 
 
 
 
 - 60 -
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 61 -
Chapter three 
 
3. RESULTS 
 
A total of seventy two patients with an interventional 
treatment done six months or more before the interview were 
included in this study. Parents and children (old age group) were 
interviewed using a questionnaire (attached as supplement) and 
data obtained.   
3.1.   Socio-demographic Character of the Study:  
3.1.1. Age and gender distribution of the study 
group: 
The age of the patients in the study group range between 
(6months -18years). Children (<1year) age were 6(8.3%), between 
(1-<5) years were 21(29.2%), between (5 <10years) were 22(30.6%), 
and between (10-18years) were 23(31.9%). Male to female ratio was 
2:1. (Figure 1, 2). 
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3.1.2. Age at diagnosis of the study group: 
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Children diagnosed of age below one month were 8 (11.1%), 
one month to less than one year were 26 (36.1%), between 1year to 
less than 5 years were 30 (41.7%), from 5 to less than 10year were  4 
(5.6%), and 4 (5.6%) children were in the age group of 10 to 18years 
at time of diagnosis. (Figure 3).     
3.1.3.   Tribe distribution of the study group: 
The majority of children in our study were from Arab tribe 
represented 52(72.2%), 7(9.7%) were Khordofani, 6(8.3%) were 
Darfori, 4(5.6%) were Bija, 2(2.9%) were Nuba and one patient 
(1.4%) belong to equatorial tribes.  (Figure 4).                          
3.1.4. Residence distribution of the study group: 
Twenty eight children in the study groups were from urban 
areas and represented (38.9%), 27(37.5%) were from rural areas, 
and the remaining 17(23.6%) were from suburban areas.  (Figure 5)  
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3.1.5.  Socioeconomic status of the study group:  
Thirty eight (52.8%) of the patients were of low 
socioeconomic state, 33(45.8%) were of moderate state, one patient 
(1.4%) belong to high social class (Figure 6).  
3.2. History and Clinical data Before and After the 
Interventional Treatment in the Study Group: 
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The study showed that the major symptoms before treatment 
were; dyspnea, cough, and recurrent chest infections and those 
represented 55(76.4%), 53(73.6%), 53(73.6%) respectively. After 
treatment 37patients (51.39%) had no symptoms. Fifteen (20.8%) of 
the symptomatic patients were found to had cough. Dyspnea and 
recurrent chest infections represented 8(11.1%) and 6(8.3%) 
respectively, (p=0.008). Other symptoms were; easy fatigue in 
45(62.5%), 42(58.3%) had failure to gain weight, 37(51.4%) had 
cyanosis, 32(44.4%) had palpitation, 27(37.5%) had difficulty in 
feeding, 27(37.5%) had frontal sweating, 27(37.5%) had a history of 
squatting during the attack of cyanosis, 14(19.4%) had chest pain, 
and 8(11.1%) had convulsion before the treatment. After the 
treatment  
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easy fatigue were 7(9.7%), 4(5.6%)had failure to gain weight, those 
with cyanosis were 10(13.9%)(p=001), palpitation were4(5.6%), 
one(1.4%) had difficulty in feeding, 12(16.7%)had frontal sweating, 
2(2.8%)remained to have squatting position, one(1.4%) had chest 
pain , and one had convulsions, as shown in (Table1). 
3.3. Health Maintenance and General Well-being: 
The study showed that 48(66.7%) expressed that their health 
and general well-being after treatment as good, 22 (30.6%) as very 
good and, and two patient (2.7%) did not feel well, as shown in 
(Table 2).  
3.4. Number of Hospitalization and Cardiac 
Complications: 
The frequency of hospital admission after treatment were as 
follow: No further hospitalization for 58(80.6%) compared to 
17(23.6%) not being admitted before treatment (p=0.02), 11(15.3%) 
had decreased frequency of hospitalization, and 3(4.2%) remained 
with a comparable frequency of hospitalization. Before treatment  
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history of heart failure (HF) was found in 11(15.3%), one patient 
had cerebrovascular accident (CVA) and one had sub acute 
bacterial endocarditis (SBE) represented (1.4%), and no history of 
arrhythmia was found before treatment. After treatment two 
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patients (2.8%) had HF, two (2.8%) developed arrhythmia, and no 
history of CVA or SBE recorded after treatment as seen in (Figure 
7,8). 
3.5.   Diagnosis: 
Results showed that from the 72 studied patient 24 (33.3%) 
were TOF, 15 (20.8%) were VSD, 5 (6.94%) were PS, 5 (6.94%) were 
PDA, 5 (6.94%) were ASD, 4 (5.6%) were AS,12 (16.7%) had 
multiple cardiac lesions and one patient (1.4%) had AVSD  (Table 
3). The type of cardiac lesions was found to be affected by the 
gender of the patients (p=0.02), where male patients represented 
(66.7%), while female were (33.3%) and the majority were cyanotic 
lesions. The type of lesion, had no effect on the patient's social 
interaction, physical activity, dependency, schooling, nutritional 
state, family caring and cardiac complications neither the growth 
state after the treatment (p>0.05).   
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3.6. Type, Number and Complications of Interventional 
Treatment:  
Patients who under went surgical procedures were 48 
(66.7%),two of them were palliative, while interventional 
catheterization patients were 19 (26.4%).Interventional treatment 
included  patients who had devices closure of VSD, PDA and ASD 
represented 2 (10.53%), 5 (26.32%), 5 (26.32%) respectively, where 5 
patients (26.32%) with PS had balloon dilatation, and 2 patients 
(10.53%) had balloon septostomy. Five patients (6.9%) had both 
surgical treatment and interventional catheterization. Sixty-four 
patients (88.9%) had one procedure though out their period of 
treatment follow up while 8patients (11.1%) had two procedures 
(Figure 9). 60 (83.3%) of the patient had no further complications 
after treatment while 12 (16.7%) developed complications which 
were; complete atrioventricular block needing permanent 
pacemaker insertion in 4 patients (5.6%), pleural effusion 4 (5.6%), 
2 patients  
 - 78 -
 - 79 -
(2.8%) had pericardial effusion and 2patients (2.8%) had 
septicemia. Period of hospitalization post interventional 
catheterization was       
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24-36 hours compared to 7 days in the surgical intervention.  58 of 
the patients (80.6%) were hospitalized for less than 7 days while 14 
patients (19.4%) stay more than 7days post procedures including 
one patient who had catheter intervention (Figure 10). Post 
interventional treatment complications seem to had no effect on 
the medication used by the patient (p=0.4).          
3.7. Duration of Follow-Up after the Interventional 
Treatment: 
Children selected for the study had been follow-up for 6 
months to 4 years; the mean was 1.08years (1.08+0.725SD). 
Duration of follow–up after treatment showed no affect on the 
health state and general well-being of patients (p=0.5), but had a 
significant effect on both weight gain (p=0.01), and patient's 
height. (p=0.05).   
3.8. Education Level, School Attendance, Days of 
Absents and Academic Performance in the Study 
Group:  
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Before treatment thirty four of the patients (47.2%) were not 
attending school or stopped schooling, 7 (9.7%) were in kinder 
garnet, 29 (40.3%) were basic school pupils, and two (2.8%) were  
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secondary school pupils(Figure 11). Before treatment 20 (52.6%) of 
those who attended school had good school attendance while 18 
(47.4%) had a poor attendance. After interventional treatment 32 
(84.2%) were found to have good attendance, where as 6 (15.8%) 
remained to have poor attendance (p=0.1). Regarding academic 
performance; before treatment 17 (44.7%) had good performance, 9 
(23.7%) had fair performance, 8 (21.1%) had excellent performance, 
and 4(10.5%) had poor performance. After treatment the 
percentage remained the same for those with good and excellent 
performance and increased in fair performance to 12 (31.6%) while 
one patient (2.6%) remained with poor performance (p=0.00) 
(Figure 12). 21 (55.3%) of those attending school had a frequency of 
absentism of more than 4days per week, while 5 (6.9%) used 
absent themselves for2-4days per week, and 12 (31.6%) for less 
than two days per week before treatment. After treatment 32 
patients (84.2%) had less than two days of absentism and 6 (15.8%) 
had more than 4days of absentism (Figure 13). 
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3.9. Physical Activity after the Interventional Treatment 
in the Study Group: 
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From the 72 patients of our study group, 66 (91.7%) of them 
showed better activity while 4 patients (5.6%) remained with the 
same activity and two (2.8%) had less physical activity. According 
to the NYHA classification the majority of the patients before 
treatment were in NYHA class11 and represented 39 (54.1%) while 
8 (11.1%) were in class 1, 7 (9.7%) were in class111, and 3 (4.2%) 
were in NYHA class1v and 15(20.9%) had no dyspnea. After 
treatment 7 (9.7%) of them remained in NYHA class11, 27 (37.5%) 
were in class1, and 1 (1.4%) was in class111, while37 (51.4%) had no 
dyspnea (p=0.008).  
3.10. The Social Interaction after the Interventional 
Treatment in the Study Group: 
Sixty six of the patients (91.7%) developed better interaction 
while two patients (2.8%) were depressed and two (2.8%) 
remained at the same level of interaction. Both physical activity 
and hemoglobin level were found to have an effect on the child's 
social interaction (p=0.00) (p=0.01), respectively(Figure 14).   
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3.11. Family Care of the Child after the Interventional 
Treatment:  
The family offered less care compared to that before 
treatment for 34 patients (47.2%), 24 (33.3%) had more care from 
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family and 14 (19.4%) remained to have same care. Family caring 
of the child had no effect on his/her social interaction (p=0.6) 
(Figure 15).  
3.12. The Child Dependency on the Family after the 
Interventional Treatment: 
Forty-three of the patients (59.7%) became less dependant 
on their families, 21 (29.2%) remained with the same dependency 
while 8 (11.1%) became more dependent. No effect of the child's 
dependency was reported on his/her social interaction (p=0.12) 
(Figure 16). 
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3.13. The Nutritional Intake after the Interventional 
Treatment:  
The study showed that 57 (79.2%) of the patients had 
increased nutritional intake, 9(12.5%) had the same intake and6 
(8.3%) had fewer intakes compared to that before the treatment.  
(Figure 17) 
 3.14.   Medications: 
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  The study showed that 49(68.1%) had no more medical 
therapy after the interventional treatment, 14(19.4%) had 
decreased number of medication, 7(9.7%) had more medication 
and two patient remained to have the same medical treatment 
(Figure 18) . 
3.15. Developmental Progress: 
Before treatment gross motor delay was found in 25(34.7%) 
of the patients, fine motor delay in 19 (26.4%), 4 patient (5.6%) had 
social delay and 3 patient (4.2%) had language delay. After 
treatment nine patients (12.5%) remained with gross motor delay, 
5 (6.9%) had fine motor delay, 3 patient (4.2%) had language delay 
and no patient had social delay (p=0.032) (Figure 19).  
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3.16. Physical Examination: 
3.16.1. General examination: 
Before treatment 65 patients (90.3%) looked ill while 6 
(8.3%) remained ill after treatment. Fourteen patients (19.4%) were 
pale, and 30 (41.7%) had cyanosis, two patient had plethora and 
two had lower limb edema each represented (2.8%). After 
treatment two patients  (2.8%) were pale, 12(16.7%) patients were 
cyanotic and no patient was found to have plethora or lower limb 
edema. 
3.16.2. Vital signs: 
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3.16.2.1. The pulse: Before treatment, from the 72 patients 
studied, 5 (6.9%) were found to have abnormal heart rate 
(tachycardia), with no abnormality in rhythm. The pulse volume 
was found to be small in 5 patients (6.9%), collapsing in 9 patients 
(12.5%), 7 patients (9.7%) lost the synchronicity of the pulse, 5 
(6.9%) had radio femoral delay and 3 patients (4.2%) had absent 
femoral pulses. After treatment 4 patients (5.6%) had tachycardia, 
4 patients (5.6%) developed irregular rhythm and they need 
permanent pacemaker. All patients had normal volume, 
synchronous pulse with no radio femoral delay.  
3.16.2.2. Blood pressure (BP): 
Before treatment 65 patients (90.3%) had a normal BP, 4 patients 
were (5.6%) found to have a high BP, and 3(4.2%) had a low BP. 
None of the patients had abnormal BP after the treatment.  
 3.16.3. Anthropometric measures by Z-score: 
3.16.3.1. Height for age before the interventional treatment: 
The study showed that 11patients (15.3%) were (<-3) z-
score,12 (16.7%) were, (-3to-2.01) z-score, 18 (25%) were (-2 to-1.01) 
z-score, 20 (27.8%) were (-1.00to 0.00) z-score, 7(9.6%) were (0.01to-
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1.00) z-score 2(2.8%) were (1.01to-2.00) z-score, 2(2.8%) were 
(>2.00) z-score (Table 4). 
3.16.3.2. Height for age after the interventional treatment: 
After treatment 10patients(13.9%) were (<-3) z-score, 12 
(16.7%) were (-3- -2.01) z- score, 21 (29.2%) were (-2to-1.01) z-score, 
20 (27.8%) were (-1.00-0.00) z-score, 7 (9.6%) were (0.01-1.00) z-
score, 1 (1.4%) was (0.01-2) z-score, 1(1.4%) was (>2.00) (p=0.00) 
(Table 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 - 97 -
 
 
 
 
 
 
 
 
3.16.3.3. Weight for age before the interventional treatment: 
The study showed that 16patients (22.2%) were (<-3) z-score 
weight for age, 23 (31.9%) were (-3to-2.01) z-score, 19 (26.4%) were 
(-2to-1.01) z-score, 12 (16.7%) were (-1.00-0.00) z-score, 1(1.4%) was 
(0.01- 1.00) z-score, 1 (1.4%) was (>2.00) z-score (Table5). 
3.16.3.4. Weight for age after the interventional treatment: 
  Nine patients (12.5%) were (<-3) z-score, 18(25%) were (-3- 
2.01) z-score, 22(30.6%) were (-2to-1.01) z-score, 20(27.8%) were (-
1.00-0.00) z-score, 1(1.4%) was (0.01-1) z-score, one patient(1.4%) 
was (1.01-2) z-score, and one patient(1.4%) was (>2.00) z-score 
(p=0.001) (Table 5) . 
3.16.3.5. Weight for height before interventional treatment: 
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Nine patients (12.5%) were (<-3) z-score, 18(25%) were (-
3to-2.01) z-score, 12(16.7%) were (-2to-1.01) z-score, 26(36.1%) were 
(-1.00- 0.00) z-score, 5(6.9%) were (0.01- 2.00) z-score, 1(1.4%) were 
(1.01- 2.00) z-score, 1(1.4%) were (>2.00) z-score (Table6).  
3.16.3.6. Weight for height after the interventional 
treatment: 
Four patients (5.6%) were (<-3) z-score, 10(13.9%) were (-3to 
-2.01) z-score, 13(18.1%) were (-2to-1.01) z-score, 34(47.2%) were(-
1.00 to-0.00) z-score, 8(11.1%) were (0.01-1) z-score, and 3patient 
(4.2%) were (1.01-2) z-score (p=0.00) (Table 6). 
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 3.16.4. Cardiovascular examination (CVS): 
Before treatment; the study showed 11(15.3%) of the 
patients had abnormally located apex beat, 7(9.7%) had a 
abnormal beat character, 4(5.6%) had left a Para sternal heave 
(LPH), 33(45.8%) had a thrill and 67(93.1%) had a murmur, and 
4(5.6%) were found to have basal lung crackles.  After treatment 
6(8.3%) had a abnormally located apex, 4(5.6%) had an abnormal  
character, one patient(1.4%) had a LPH, 5(6.9%)had a palpable 
second heart sound , 22 patients (30.6%) had a thrill and 55(76.4%) 
had a murmur, no patient was found to have basal lung crackles, 
and 67(93.1%)had improved oxygen saturation after the treatment, 
as the saturation was ranging from (65%-100%)before treatment 
to(91%-100%) after treatment.         
3.16.5. Abdominal examination: 
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Before treatment; liver enlargement was found in 9 patients 
(12.5%) while one patient had a splenomegly and one patient had 
ascites, each represented (1.4%). After treatment none of the 
patients showed abnormal abdominal findings.  
 
3.16.6. Central nervous system examination (CNS): 
Before treatment; it was found that three patients (4.2%) 
had an abnormal CNS examination. Two out of three patients 
(2.8%) had generalized hypotonia and one (1.4%) had a 
hemiplegia. After treatment one patient remained hypotonic and 
one hemiplegic, each represented (1.4%), while one patient 
developed a new spastic quadriplegia (1.4%). 
 
3.17. Hematological Indices (Hb%, PCV) and Post 
Interventional treatment cardiac investigations:  
3.17.1. Hematological indices (Hb%, PCV): 
Abnormal hematological indices before treatment were 
found in 33 (45.8%) of the patients, as 20 of them (27.8%) were 
found anemic and 13 (18%) polycythemic. After treatment 5 
patients had abnormal indices (6.9%), all were found to be anemic 
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and none had polycythemia(Table 7) . The blood indices showed 
improvement that was not statistical significant, and were found to 
have no effect on the growth state after treatment (p=0.5).  
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3.17.2. Cardiac investigations; (Echocardiography and catheter 
results):  
After treatment echocardiography was abnormal in 21 
patients (29.2%) with a mild shunt residual in 10(13.9%) and with 
significant shunt residual in 11 patients (15.3%). Two patients 
(2.8%) where recatheterized after treatment; one had surgical 
pulmonary valvotomy and post operative catheterization showed 
severe pulmonary stenosis, and the other had palliative 
pulmonary artery band and post operative catheterization showed 
high pressure gradient of the main pulmonary artery (i-e loose 
band).               
The residual cardiac lesions after the interventional 
treatment was found to affect the social interaction (p=0.01), but 
showed no significant effect on NYHA classification (p=0.2), the 
child's physical activity (p=0.2), his dependency on his family 
(p=0.7), his nutritional intake (p=0.4), his general well-being 
(p=0.8) or his growth state (p=0.4).  
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3.18. Quality of Life Scores: 
A QOL score consisting of: (1) signs and symptoms (2) 
general well-being (3) frequency of hospitalization (4) growth state 
(5) social interaction (6) physical activity (7) dependency on the 
family. 
The possible maximum score for the QOL was 10. The 
attained outcome score ranged from 2 to10. Sixty four of the 
patients (88.89%) had a good QOL in the different aspects 
mentioned above, as they score more than (70%), while poor QOL 
outcome was found in eight patients (11.11%) as shown in (Figure 
20). 
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Chapter four 
4. DISCUSSION 
 
The study was designed to evaluate the quality of life after 
cardiac interventional treatment in different aspects; including 
general well-being, complications, frequency of hospitalization, 
growth and developmental progress, physical activity, social 
interaction, education and academic performance, family caring 
and child dependency on the family; all  compared to those before 
interventional treatment.  
4.1. Socio-Demographic Characteristic of the Study 
Group: 
4.1.1. Age and gender distribution of the study group: 
Large number of the patients (31.9%) was between 10-18 
years. The median age at the time of the study was 7years, the 
range being 6months to 18years. That was different from 
Mccrindle study which reported median age of 2.9 years, ranging 
from one day to 20years (115). This may be due to the recent 
introduction of cardiac interventional treatment in Sudan and that 
surgery is done at an older age due to late diagnosis and limited 
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technical facilities as surgery for patients weighting less than 7kg 
needs specialized post operative intensive care facilities. This is 
currently not available in Sudan and open heart surgery is not 
usually done below 7kg. Regarding gender distribution, the study 
showed that 66.7%were males and 33.3% were females.  This goes 
with the findings of the previous study. 
4.1.2. Age at diagnosis and Age at intervention of the study 
group:  
 Although there was some improvement in detecting 
patients with CHD in Sudan, a large percentage of patients (41.7%) 
were diagnosed after one year of age, and (52.8%) had 
interventional treatment after age of 5 years which was late 
compared to Western literature as in Renato study (54)  
4.1.3. Tribe distribution of the study group: 
The study includes most of the ethnic groups and showed 
that 72.2% of the patients were from Arab tribes, reflecting the 
representation of this ethnic group in the community, and is 
consistent with previous studies in Sudan(21,24).   
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4.1.4.   Residence Distribution of the Study Group: 
The majority of the study group came from urban areas. 
This was consistent with the fact that, urban population benefited 
most from health services, and is consistent with previous study in 
Sudan(24).  
4.1.5. Socioeconomic status of the study group:  
Most of patients (52.8%), were of a low socioeconomic 
status in contrast to the findings in a previous study which 
showed (51%) of the patients belong to moderate social class (24) 
This reflects the availability of such treatment to all community 
classes inspite of its cost. Fortunately this socioeconomic 
background did not influence children's social interaction post 
intervention (p=0.7), this reflects  sociality as part of our culture in 
the community. 
4.2. Clinical Data Before and After the Interventional 
Treatment in the Study Group: 
  The study showed that 72.2% of the patients had no 
symptoms after treatment. The most frequent pretreatment 
symptoms were; dyspnea, cough and recurrent chest infections 
and had improved significantly after treatment (p=0.008). This 
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result was different from the Australian result as 93% of their 
patients found to be asymptomatic after treatment(86).  These 
differences are explained by the differences in the set-up of the 
centre in developed countries, however our results are acceptable 
when we consider our limited facilities.  
    The general physical examination of the study group was 
acceptable after treatment as (91.7%) of them looked well. There 
was ongoing neurological deficit in 2.4% which was consistent 
with research findings from Canada by Limperopoulos(138).    
4.3.   Health Maintenance and General Well-Being: 
Most of the patients in the study group (97.3%) felt that 
their general health was good and very good after treatment which 
was higher than results obtained from Netherlands by Meijboom, 
where 84% were in good health(89). It can be explained by the long 
duration of follow-up after the procedure as it was14.5+2.6 year in 
the study mentioned above, compared to maximum of 4year in 
our study group and the fact that in the latter study more complex 
surgery was done and patients were younger.                                                                
4.4. Number of Hospitalization and Cardiac 
Complications: 
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The study showed that there was significant improvement 
in patient frequency of hospitalization (p=0.02) as 80.6% had no 
further admissions. Hospitalization due to cardiac complication 
was also improved as 2.8% developed HF compared to15.3%before 
treatment, with no more CVA or SBE among them. This result was 
acceptable according to our set up in Sudan.  
4.5.   Diagnosis: 
 The most common diagnosis was TOF which represented 
33.3%, others diagnosis were VSD, ASD, PDA, PS, AS, multiple 
cardiac lesions and AVSD. This is not consistent with the results 
from Finland where the acyanotic group were the most common 
lesions(110).  It reflects the fact that TOF patients tend to be 
diagnosed late and survive longer. The type of the cardiac lesion 
had significant correlation with the gender of the patients (p=0.02), 
as most of the cyanotic patients were male with a ratio of 2:1. We 
found that there was no direct effect of the type of the cardiac 
lesion on the child interaction, playing activity, dependency, 
family caring, nutritional intake, school level and attendance or 
performance neither on the complication, growth or development 
in all its aspects (p>0.05).This is probably due to the short follow-
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up period in our study group, and the insignificant residual 
together with the improvement in the blood indices after 
treatment.    
4.6. Type, Number and Complications of Interventional 
Treatment:  
The study showed that 88.9% of the patients had one 
procedure throughout the period of treatment and follow up, and 
only 8 patients had a second procedure. 12patients (16.7%) 
developed complication after intervention, this incidence was 
higher compared to 4.1% reported by Agnoletti from France (91) 
and to 8.8% reported by Renato from Toronto(54), although they 
interfere in large number of patients compared to that in  our 
study.  The major complication was found to be complete heart 
block represented 5.6% compared to (0.41%) in the previous 
study(54).  This complication needed life long follow up as the 
pacemaker will need change every 8to10years which is a burden 
on the child and family. Pleural effusion represented 5.6%, and 
19.4% of those patients needed admission for more than one week 
after treatment, however, this is usually a transient complication. 
The results was found to be comparable to the findings by 
 - 112 -
Meijboom from Netherlands where 89% of the patients were found 
to be free of a second intervention, but in their study the number 
of patients was larger  and period of follow-up was long(14.5 
year)(89), compared to maximum of 4years in our study. Post 
interventional complication had no effect on the use of cardiac 
medication (p=0.4), as most of these complication were transient 
apart from those needed pacing. The duration of follow up was 
found to have no significant effect on the general well-being of the 
patients (p=0.5). This might be explained by the immediate 
improvement of hemodynamic state after intervention.   
 
 
 
 
4.7. Education Level, School Attendance, Days of 
Absence and Academic Performance in the Study 
Group:  
Before treatment 34 patients (47.2%) were not attending 
school before treatment, that was higher than found by Samanek 
were (35.5%) had delay school attendance (97). This is probably 
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due to the impact of the illness before treatment, and to family's 
overprotection, that reflects negatively on their schooling and self 
dependency. 
  Many of our study group were basic school pupil (40.5%), 
among them (27.8%) had good attendance. Although there was 
post interventional improvement in their attendance (43.1%), it did 
not reach statistical significance (p=0.1). 23.6% of the children had 
good performance, 12.5% were fair, and 11.1% were excellent, 
while poor performance were5.6%.They showed significant 
improvement after treatment (p=0.00), where one patient remained 
with poor performance 1.4%.   
 
 
4.8. Physical activity after the Interventional Treatment 
in the Study Group: 
The majority of the patients (91.7%) showed better activity, 
(5.6%) remained in the same activity and (2.8%) became less active. 
The majority of the patients were in NYHA class11and1 showing 
significant improvement after treatment (p=0.033). This is 
consistent with findings from Australia by Tefuarani(86). They 
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related their symptoms to the presence of mild pulmonary 
hypertension and the presence of residual defects. The small 
number of patients in our results can be related to the increased 
incidence of residual defects or to lack of education regarding the  
physical activities guide line, unlike the case in Martil`s results(99)), 
where they found restriction of patients activities after the 
procedure which was not standardized by the guide line of 
activities.  
4.9. Social Interaction after the Interventional Treatment:  
Sixty six of the patients (91.7%) developed better 
interaction, while two patient (2.8%) were depressed and two 
(2.8%) remained at the same level of interaction. This is not 
consistent with the findings of Mccrindle where behavior 
problems were found in (23%) of the patients, anxiety in (17%), 
and depression in (17%)(115).  It could be explained because less 
number of interventions was performed in our study group, and 
the shorter interval period of follow-up. The improvement of the 
hemodynamic status and physical activity, influence children 
interaction significantly (p=0.01) (p=0.00). This can be explained by 
the Turkish researchers findings where they identified worsening 
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and severity of the hemodynamic status at surgical repair as 
predictive factors of behavioral problem(114).  
4.10. Family Care of the Child after the Interventional 
Treatment:  
Before treatment (52.7%) of the patients families paid the 
same or more care towards their child's health state, while (47%) 
received less attention. This reflects the need to involve the family 
as an important part of the management and to insure having 
accurate information, and to reinforce the positive, normal 
contribution towards their children's management. 
 
4.11. The Child Dependency on the Family after the 
Interventional Treatment: 
Many of our study group (40.3%) was still dependant on 
their families after treatment. This goes with the findings of Utens 
(119), who reported that leading a dependant life was the most 
common negative effect. Our results reflect the need to encourage 
families to guide their children toward independency and to have 
a positive contribution toward their daily life. This dependency 
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did not affect their social interaction (p=0.12), probably due to the 
improvement of their general health state. 
4.12. The Nutritional Intake after the Interventional 
Treatment:  
The study showed that 57 (79.2%) of the patients had 
increased nutritional intake, 9(12.5%) had the same intake and 6 
(8.3%) had less intake compared to that before the treatment. This 
reflects the degree of improvement in general well-being and 
physical state. 
   
4.13. Medications: 
The study showed that 49(68.1%) had no more medical 
therapy after interventional treatment, and that was not consistent 
with the result found by Meijboom from Netherlands  where 
89%had been free of medications(109).   This might be related to the 
higher incidence of residual lesions in our study group. 
4.14. Developmental Progress: 
After treatment (12.5%) of the patients had gross motor 
delay, (6.9%) had fine motor delay and (4.2%) had language delay. 
motor The results showed deficiency in the GM/FM and language 
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which was consistent with the findings reported by Wray, 
Limeripoulos  and Weinberg(110,138,139). This might be related to 
maternal overprotection that hinders their motor progress. There 
was significant improvement in the social component (p=0.032). 
We found no significant correlation of the duration of follow up 
after the intervention and the developmental progress (p>0.05) in 
all it is aspect. This in fact reflects the nature of such lesions.  
 
4.15.  Anthropometric measures by Z-score: 
The study showed that before treatment severe 
malnutrition was reported in 37.5% (WHZ >-3), and moderate to 
mild malnutrition in 62.5%. After treatment, these figures dropped 
to 30.5% for severe malnourish, and 69.4% became moderate 
malnutrition. The results reflects significant improvement in their 
weights, and heights after treatment (WAZ, WHZ, HAZ) 
(p=0.001), (p=0.00), (p=0.00), respectively. The duration of follow-
up after treatment had positive correlation with the weight 
(p=0.01) and weight for height (p=0.05). No difference between the 
type of cardiac diagnosis on the different aspects of the growth 
(p>0.05), and the growth found to have no effects on children's 
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gender (p>0.05) after treatment. This probably due to the 
improvement of their general well-being, hematological indices 
and the insignificant shunt residual after treatment in both sexes. 
 
 
4.16. Hematological Indices (Hb%, PCV) and Post 
Interventional Treatment Cardiac Investigations:  
4.16.1. Hematological indices (Hb%, PCV): 
Abnormal hematological indices were found in (45.8%) of 
the patients; (27.8%) of them were anemic and (18%) were 
polycythemic. Improvement after treatment was notice but did not 
reach statistical significant (p>0.05).Where (6.9%) of the patients 
had abnormal indices; anemia was found in (5.6%) and none of the 
patients had polycythemia. There was no correlation between the 
hemoglobin state and the growth (p>0.05) after treatment. This 
reflects the fact that many other factors contributed to growth 
process, like for psychological state. 
4.17.2. Cardiac investigations; (Echocardiography and Catheter 
results):  
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Residuals lesions were found in (29.2%) of the patients after 
treatment; (15.3%) of these residuals were insignificant. The study 
showed positive correlation (p=0.01) of the shunt residual on the 
interaction, but not on the physical activity, child dependency on 
family, the nutritional intake or the general wellbeing (p>0.05). 
This could be explained by the fact that most of most of these 
residual lesions were insignificant. 
4.17. Quality of Life Scores: 
The majority of the patients (88.89%) were found to have 
good QOL; that was done by evaluating the aspects of signs and 
symptoms, general well-being, frequency of hospitalization, 
growth state, social interaction, physical activity, and dependency 
on family of the study group. While 11.11% of the patients were 
found to have poor QOL. The results were encouraging especially 
in our current set-up, but more efforts are needed to improve QOL 
of these children. Early diagnosis and early establishment of 
medical and interventional treatment is vital to improve QOL. This 
needs increasing awareness of physicians and pediatricians about 
CHD and also needs availability of catheterization and surgery at 
affordable cost. After treatment, social and nutritional advice 
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should continue to consolidate the general wellbeing that follows 
treatment. Parents can be encouraged to form support groups to 
discuss the problems of their children with each other and with 
health care providers. 
4.2. CONCLUSION  
• Most children with congenital heart disease were diagnosed 
late after the age of one year, and almost half of them had 
interventional therapy after the age of five.   
• Interventional cardiac treatment (catheter based and 
surgical) for most of the common CHD is available to 
children in Sudan even to those of low socioeconomic class 
inspite of its cost. 
• There was significant improvement of QOL regarding 
general well-being, health state and frequency of 
hospitalization after treatment.  
• The majority of the patients showed much improvement in 
their physical activity, social interaction and 68.1% needed 
no more medication after intervention. 
• Interventional therapy had significant positive effects on the 
weight and height of the patients.  
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• There was improvement on the motor development that was 
not statistically significant after treatment.   
• Disappointingly, family over caring hindered children's 
schooling and leading of independent life. 
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4.3.  RECOMMENDATIONS  
1. Early detection of CHD by increasing awareness of medical 
staff and improving the rate of referral to the cardiac centres. 
2. Awareness of preventive measures helps in decrease the 
prevalence of congenital heart disease. 
3. Improving and upgrading of the available cardiac 
interventional facilities to include larger numbers of patients; 
younger age groups and wider range of interventions at 
affordable cost.  
4. Introduction of cardiac services for the management of these 
patients in both large cities and suburban areas.  
5. Promotion of parents` health education directly or through 
support groups to ensure their cooperation and full 
understanding of their children conditions.  
6. Long- term follows up studies of these children are needed to 
look at their QOL.  
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Quality of life after interventional treatment in congenital heart disease Sudanese 
children 
 
Questionnaire 
 
0- Study DATA  
serial No.               Tel No. : ………………… 
                               Date     : ………………… 
1- Personal data  
1-1 Name : ……………… 
1-2 Age    : ……………… 
1-2 Age group :         a- (6/12 ــ < 1y )             b- ( 1y ــ < 5y)  
                                          c- (5 ــ < 10)      d- (10 ــ 18)  
1-3 Age at Diagnosis        a- (< 1 month)    b- (1/12 ــ < 1yr.)  
c- (1y ــ 5y)                   d- (>5 ــ < 10)    
e- (10 ــ 18)  
1-4 Gender                   a- (male)             b- (female)  
1-5 Ethic group: ………………….. 
1-6 Residence:   a- Rural      b- Urban     c- Sub urban  
2- Symptoms at time of interview versus symptoms before treatment       
                                                                                       before treat.  After treat. 
2-0 Dyspnoea        a- yes                b- no                    
 
2-1 NYHA   a- class  I          b- class II    
c- class  III         d- class IV 
2-2 cough                1- yes               2- no   
2-3 Bluish discoloration            1- yes               2- no 
2-4 Recurrent chest infection    1- yes               2- no 
2-5 palpitation      1- yes               2- no 
2-6 Difficulty in Feeding   1- yes               2- no 
2-7 Frontal Sweating     1- yes               2- no 
2-8 Squatting      1- yes               2- no 
2-9 Easy Fatigue      1- yes               2- no 
2-10 Failure to gain wt     1- yes               2- no 
2-11 increase wt gain     1- yes               2- no 
2-12 convulsion      1- yes               2- no 
2-13 chest pain      1- yes               2- no 
2-14 Is he/shegenerally well being?      1- yes               2- no 
     3- Past History from medical records         . 
3-1 Number of hospital admission after treatment 1-increased     2-decreased    3-none 
  2
 
 
3-2 history of heart failure    a- yes  b- no 
3-3 H of Arrythmia   a- yes  b- no  
3-4 H of stroke (CVA)   a- yes  b- no 
3-5 H of SBE     a- yes  b- no 
3-6 other specify ………………..      
3-7 No and Types of intervention treatment received:     1- type     a- surgery b-catheter 
                                                                                          2- Number …………………………. 
                                                                                          3- Complication   a- yes           b- no 
                                                                                          4- Hospital stay    a- ≤7days b- >7 days 
                                                                                                                                       5-period after treatment……… 
4- Development history             before              after 
4-1 Early childhood development  a- normal          b- delay 
4-1-1 Gross motor      a-normal      b-delay  
4-1-2 Fine motor      a- normal)     b- delay   
4-1-3 Social     a- normal     b- delay 
4-1-4 Language    a- normal     b- delay 
4-2 School level:  
a- Kindergarten     b- Basic School      c- Secondary School  
      d-none                  Before            After  
4-3 School attendance     a- poor   B- good   
4-5 School performance   a- Excellent     b- good     c- Fair       d- poor  
4-6 No. of days absent from school per week    a- < 2days   b- 2-4 days   c- > 4 days       
6- Diagnosis:               a- VSD      b- ASD    
c- AVSD    d- PDA            e- AS        
                          f- PS                    g-TOF              h- TGA     I- other    
7- Social history & personal        
7-1 Interaction after treatment        
a- depress        b- interact    c-The same  
7-2 Playing activity after treatment 
    a- less   b-the same  c- better  
7-3 Family care to the child after treatment compare to before treatment    
a- same   b- less       c- more  
7-4 Child dependency on family after treatment compare to before treatment:    
a- same     b- less     c- more  
7-5 Nutritional intake after treatment compared t o before treatment 
    a- same     b- less     c- more  
7-6 Socioeconomic state   a- low    b- moderate   c- high  
8. Drug history: 
8.1 Number of medication after treatment: 
 a- None   b decreased   c- the same  d- increased   
9. Physical examination: 
9.1 Anthropometric measurements: 
9.1.1 weight  
a- wt before treatment ………………kg 
b- wt after treatment ……………… kg 
9-1-2 height /length ………………. cm  
1- before treatment ………… cm  
2- after   treatment …………. cm  
9-1-3 Wt / Ht  Z score  before treatment ……    a- mild       b- moderate      c- sever 
  3
      
          Wt / Ht  Z score  after  treatment ……… a- mild       b- moderate      c- sever      
9.2 Developmental assessment: 
    1) Normal   2) Abnormal  before     after 
a- GM 
b- FM 
c- Social 
d- Language 
9-3 General   
a- Look             1- well        2- ill    
       b- Anaemia        1- yes        2- no  
       c- Cyanosis         1- yes        2- no 
       d- Plethora         1- yes        2- no 
       e- L.L oedema             1- yes        2- no 
9-3 CVS  9-3-1  pulse  …………. 
9-3-1   Rate                 a- normal     b- tachycardia    c- bradycardia  
9-3-2   rhythm             a- regular     b- irregular  
9-3-3   volume            a- normal  b- small   c- large  
9-3-4 collapse             a- yes           b- no  
9-3-5 syncrous            a- yes           b- no 
9-3-6 R.F. delay          a- yes           b- no 
9-3-7 peripheral pulse a- yes           b- no 
9-3-8  BP…………     a- normal       b- high    c- low  
9-3-9 pericordum   
 i- apex location    a- normal     b- abnormal  
 ii- apex character    a- normal     b- abnormal 
 iii- LPH                       a- yes                 b- no  
 iv- P2 palpable            a- yes                 b- no  
 v- Thrill                      a- yes                 b- no  
 vi- Murmer                  a- yes                 b- no  
 g- Oxygen Saturation improve a-yes                           b-no 
……  
9-3-10 Chest: basal crackle     a- yes             b- no  
9-3-11 abdomen           
 i- Spleen          1) present      a- yes               b- no   
2) If present, a- enlarge  b- reduced  
 ii- Liver 1) present      a- yes               b- no   
2) If present,  a- enlarge  b- reduced 
 iii- Ascites 1) present      a- yes               b- no   
2) If present,  a- enlarge  b- reduced 
9.3.12 CNS  i)   a- Normal  b- Abnormal  
ii) if Abnormal,   
               Specify ………… 
9.4 Investigation:           before       after 
 a.  Hb: ……..     a. normal  b. abnormal   1-highy     2-low 
 b. PCV ……… a- normal  b. abnormal 1-higy     2-low 
  
c. Echo finding (after treatment):  
`I) shunt residual:      1. Yes  2. No 
II) If yes, 
 1. Significant                           2. Not significant 
e. Catheter result in those need post-operative catheterization……………….. 
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